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ABSTRACT
RESCUING AGE-RELATED PROTEOLYSIS DEFICITS WITH METHYLENE BLUE
by
Shane Pullins
University of Wisconsin – Milwaukee, 2017
Under the Supervision of Professor Fred Helmstetter
The average lifespan is constantly increasing with the advent of new medical techniques,
and age-related cognitive decline is becoming a prevalent societal issue. Even during healthy
aging, humans and rats exhibit progressive deficits in episodic/declarative memory. In
laboratory rats, age-related memory impairment can be assessed with trace fear conditioning
(TFC). Recent research implicates ubiquitin proteasome system-mediated protein degradation in
the synaptic plasticity supporting memory formation and retrieval. In rats, aging leads to
decreased basal proteolytic activity in brain structures known to support the acquisition and
retrieval of trace fear memories, and our preliminary data suggests activity-dependent
proteasome activity declines in a similar fashion. The proposed experiments sought to rescue
age-related decreases in plasticity-related protein degradation during memory consolidation via
proteasome stimulation with the compound methylthioninium chloride (methylene blue [MB]).
Intraperitoneal post-training MB administration at 1, 4, or 16mg/kg did not improve memory
performance, chymotrypsin-like, or trypsin-like proteasome activity in young or aged rats in any
of the four brain structures examined. Additionally, dietary treatment with MB for four months
did not enhance memory, chymotrypsin-like, or trypsin-like proteasome activity in young or
aged animals. These results suggest that MB may not be well suited to augment fear learning or
to upregulate general proteasome activity. Future work should investigate other means of
proteasome stimulation and subsequent rescue of cognitive decline during aging.
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INTRODUCTION
Normal Aging and Memory in Humans
Aging is common to all organisms; lifespans are finite, and typically a number of
biological processes go awry with increasing age. The past century has yielded a remarkable
increase in life expectancy, and one notable burden of this newfound longevity is a decline in
cognitive ability (Hedden & Gabrieli, 2004). Senescence-related effects exist on a continuum
ranging from pathological aging, wherein myriad pathologies including Alzheimer’s and
Parkinson’s diseases may develop, to successful aging, wherein individuals do not display
significant age-related deficits in cognitive ability (Rowe & Kahn, 1987). Most individuals
qualitatively age somewhere between pathological and successful aging, in a pattern termed
normal cognitive aging (Roberson et al., 2012). Even during normal cognitive aging, mnemonic
function declines and these impairments often negatively affect societal function, independent
living, and overall health (Petersen, Smith, Kokmen, Ivnik, & Tangalos, 1992). The proportion
of the U.S. population aged over 65 years is projected to more than double by the year 2050 and
one out of five individuals will be classified as aged (Ortman, Velkoff, & Hogan, 2014). With an
increasing number of aged individuals, and subsequent increased prevalence of cognitive aging,
our healthcare system will undoubtedly experience severe strain. As such, combatting agerelated cognitive decline is one of the most important issues facing the neuroscientific
community.
Normal aging does not globally affect mnemonic processes, rather, certain types of
memory are more susceptible to age-related impairments (Drag & Bieliauskas, 2010). Memory
can be broadly divided into four distinct memory systems including procedural memory,
semantic memory, working memory, and episodic memory (Tulving, 1987). Procedural memory
pertains to the acquisition and retention of behavioral skills, and seems to remain largely intact
during normal aging, although age-related motor and coordination deficits may interfere with
performance (Smith et al., 2005). Semantic memory, or “knowledge”, involves the learning and
retention of factual information, and results from the Berlin Longitudinal Study suggest that this
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form of memory remains intact until ~90 years of age (Singer, Verhaeghen, Ghisletta,
Lindenberger, & Baltes, 2003). Working memory, or the system that facilitates processing and
mentally manipulating information over short periods of time, does seem to uniformly decline
during normal aging (Gilinsky & Judd, 1994; Park et al., 2002). However, the focus of this
proposal will be on episodic memory, which displays consistent and robust age-related deficits
(L. Nilsson, Bäckman, & Erngrund, 1997).
The episodic memory system is responsible for the encoding of personal experiences and
the conscious recollection of occurrences passed; as such, use of this memory system is largely
dependent on contextual and spatial cues for proper recall of a previous episode (Nilsson, 2003;
Tulving, 1987). Numerous reports suggest a global age-related decline in episodic memory
performance, even during healthy aging (Craik & Rose, 2012; Koen & Yonelinas, 2014;
reviewed in Rönnlund, Nyberg, Bäckman, & Nilsson, 2005). Specifically, healthy aging impairs
episodic associative memory involving verbal, written, and pictorial cues (Cabeza et al., 1997;
Craik & McDowd, 1987; Daselaar, Fleck, Dobbins, Madden, & Cabeza, 2006; Daselaar,
Veltman, Rombouts, Raaijmakers, & Jonker, 2003; Monti et al., 1996; Naveh-Benjamin, 2000;
Naveh-Benjamin, Hussain, Guez, & Bar-On, 2003; Provyn, Sliwinski, & Howard, 2007), and
these deficits seem to consistently manifest after ~60 years of age. Some of the strongest
evidence for a decline in spatial episodic memory in humans comes from an experiment in which
participants of various ages were brought into a science exhibit center and allowed to examine a
number of displays (Uttl & Graf, 1993). After exploring the center, one component of testing
involved asking participants to place the various items they saw on a map. Performance on this
component sharply declined after the 6 decade of life, adding support to the notion that, even in
th

normally aging participants, episodic memory performance declines after age 60 (Uttl & Graf,
1993).
Collectively, it seems that normal aging is accompanied by an episodic, associative
memory deficit wherein individuals have difficulty mentally binding elements or cues together in
time (Golomb, Peelle, Addis, & Kahana, 2008; Monti et al., 1996) and/or space (Driscoll et al.,
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2003; Newman & Kaszniak, 2000; Uttl & Graf, 1993). Together, these patterns of inability have
problematic implications, which give impetus for appropriately modeling these forms of memory
in laboratory animals for investigating and correcting age-related memory decline.
Animal Models of Memory and Aging
Fear conditioning is a powerful tool to model human episodic memory processes in
nonhuman animals. As typically performed in rodents (which will henceforth be the focus of this
proposal), this paradigm involves repeated pairings of an innocuous conditioned stimulus (CS)
with an aversive unconditioned stimulus (UCS - footshock) in order to elicit a measurable fear
response (e.g. freezing behavior). Following successful training, exposure to either the CS (a
tone in the case of auditory fear conditioning) or the training context is sufficient to elicit
freezing behavior in absence of the UCS allowing for an index of associative memory strength
(Gilmartin & Helmstetter, 2010).
Numerous variants of Pavlovian fear conditioning have been characterized. Traditionally,
in auditory fear conditioning the UCS is presented at the offset of the CS in a form of
conditioning called “delay” fear conditioning (DFC). This training paradigm can model implicit
memory in that it depends largely on subcortical structures like the amygdala (AMY) in rats and
humans, and does not require sustained attention or contingency awareness in humans (Bailey,
Kim, Sun, Thompson, & Helmstetter, 1999; Clark & Squire, 1998; Knight, Nguyen, &
Bandettini, 2006). In contrast, when the CS and UCS are separated in time by a stimulus-free
“trace interval” (TI), in a paradigm deemed trace fear conditioning (TFC), the association
between them is thought to weaken, as successful training requires a greater number of training
trials (Beylin et al., 2001; Pavlov, 2010). Importantly, the inclusion of this interval is proposed to
model explicit or episodic memory, as learning this association recruits additional brain
structures that are known to support episodic associative memory in humans (Connor & Gould,
2016). Similar to DFC, successful TFC requires the AMY, but TFC also engages the
hippocampus (HPC), prefrontal cortex (PFC), anterior cingulate cortex (ACC), and retrosplenial
cortex (RSC) due to the presumed requirement for sustained attention during the trace interval
3

and contingency awareness (Gilmartin, Miyawaki, Helmstetter, & Diba, 2013; Han et al., 2003;
Knight, Cheng, Smith, Stein, & Helmstetter, 2004; Kochli, Thompson, Fricke, Postle, & Quinn,
2015; Kwapis, Jarome, Lee, & Helmstetter, 2015; Kwapis, Jarome, Schiff, & Helmstetter, 2011;
Quinn, Oommen, Morrison, & Fanselow, 2002; Steenland, Li, & Zhuo, 2012; Weike, Schupp, &
Hamm, 2007). Finally, associative fear conditioning may also be conducted without the use of
discrete cues in a paradigm called contextual fear conditioning (CFC), which engages a similar
set of brain structures as TFC (Cowansage et al., 2014; Einarsson & Nader, 2012; Fanselow,
1980; Gilmartin & Helmstetter, 2010; Kwapis et al., 2015; Quinn, Loya, Ma, & Fanselow, 2005;
Zelikowsky, Hersman, Chawla, Barnes, & Fanselow, 2014). These various forms of fear
conditioning have yielded a greater understanding of normal memory formation and retrieval,
but importantly, they have also been applied to the problem of age-related deficits in learning
and memory.
The pattern of cognitive decline during healthy aging seems to be conserved across
species (Erickson & Barnes, 2003). Moreover, this pattern seems to implicate dysfunction within
brain structures critical to memory that comprise the medial temporal lobe (MTL - Barnes,
1998). Support for this comes from investigations of memory performance in tasks that are
known to be MTL-dependent (Driscoll & Sutherland, 2005). Relative to young rats, aged rats
exhibit deficits when tested on the Morris water maze in the fixed position task (which assesses
spatial memory), the repeated acquisition task (which assesses spatial working memory), as well
as in discrimination procedures (Driscoll et al., 2006; Frick, Baxter, Markowska, Olton, & Price,
1995; Gallagher, Burwell, & Burchinal, 1993). Importantly, these deficits are not due to general
age-related performance effects, and seem to arise from specific hippocampal dysfunction
(Driscoll et al., 2006; Gallagher et al., 1993). Similarly, age-related spatial memory impairments
extend to deficits for contextual memory in CFC procedures, which are also sensitive to
manipulations of the MTL (Houston, Stevenson, McNaughton, & Barnes, 1999; Moyer &
Brown, 2006; Oler & Markus, 1998; Stoehr & Wenk, 1995; Ward, Oler, & Markus, 1999).
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While aged rats seem to be impaired in navigation and fear conditioning paradigms that
do not involve discrete cues (i.e. CFC procedures), an interesting dichotomy arises within cued
auditory fear conditioning. Following DFC, aged rats display reduced memory for the training
context, but normal memory for the training tone (Houston et al., 1999; Oler & Markus, 1998;
Stoehr & Wenk, 1995; Ward et al., 1999). However, in TFC procedures, aged rats exhibit
deficits to the training context and the training tone (McEchron, Cheng, & Gilmartin, 2004;
Moyer & Brown, 2006; Villarreal, Dykes, & Barea-Rodriguez, 2004). Moyer and Brown (2006)
examined this selective deficit in TFC and incorporated a control for differences in inter-stimulus
interval lengths between the two training procedures. Aged rats were trained in either TFC,
consisting of a 15s tone and a 30s TI prior to each footshock, or long-DFC, consisting of a 45s
tone co-terminating with a footshock. They found that aged rats had no difficulty learning about
the training tone in long-DFC procedures, relative to TFC. Additionally, they performed
important control experiments to determine that this deficit in TFC was not due to decreased
shock perception or differences in activity levels between young and aged rats (Moyer & Brown,
2006). Thus, aged rats display reduced associative memory for the tone and footshock only when
the two are separated in time, a feature that makes this learning paradigm a good model of
episodic memory. This finding corroborates the previously mentioned idea that MTL dysfunction
in humans and rodents leads to deficits in memory processing.
The details of age-related MTL dysfunction are complicated but some specific cellular
processes have been investigated. Numerous reports indicate a reduction in synaptic plasticity,
especially within the HPC. One of the principle mechanisms underlying synaptic strengthening
within the HPC is long-term potentiation (LTP). Hippocampal LTP is reduced with increasing
age (reviewed in Burke & Barnes, 2006). Two main culprits in age-related aberrant LTP are
imbalances in calcium homeostasis and N-methyl-D-aspartate receptor (NMDAR) dysfunction
(reviewed in Foster & Kumar, 2002). Additionally, LTP impairments have been attributed to
reduced surface expression of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
receptor (AMPAR) subunit GluR1, reduced dendritic αCamKII expression, imbalances in
5

kinase/phosphatase activity, reduced spine density and atuophosphorylated CamKII, and reduced
levels of CREB and phosphorylated CREB (Almaguer, Estupinan, Frey, & Bergado, 2002; Chen
et al., 2015; Davis et al., 2000; Jouvenceau & Dutar, 2006; Long et al., 2009; Morris & Gold,
2012). Driscoll and colleagues (2006) examined the aging hippocampus in female rats crossed
between F344 and Brown Norway hybrid strains. They found reduced hippocampal volume
when normalized to intracranial volume and reduced neuron density in aged rats. Additionally,
they quantified dividing cells with BrdU labeling, immature cells with DCX labeling, and
cycling cells with Ki67 labeling – there were significant age-related reductions in all
immunohistochemical analyses. Further, these reductions in cellular division and integrity of
mitosis, correlated with age-related deficits in performance on Morris water maze tasks
(described above). While their spectroscopy data examining metabolic health in the HPC
suggests no age related decline in this particular strain of rat, other investigations using solid
state high-resolution magic angle spinning nuclear magnetic resonance imaging have shown
decreases in concentrations of various metabolites in Long Evans rats (Driscoll et al., 2006;
Paban, Fauvelle, & Alescio-Lautier, 2010). However, it may be the case that metabolic deficits
arise during periods of increased activity or stress, as would be the case during fear learning and
subsequent memory retrieval (Galeffi, Shetty, Sadgrove, & Turner, 2015).
In conclusion, aged humans and aged rats exhibit memory deficits in tasks known to
depend on the MTL. In tandem with declines in working memory, complex associative memory
(episodic in humans, TFC in rats) seems to deteriorate with increasing age. Fear conditioning
procedures like TFC in rats provide a good model for further investigation of aberrant cellular
function in normal aging. Much is known about the neural mechanisms of HPC dysfunction with
increasing age, but an exhaustive examination of age-related effects on cellular processing
remains incomplete.
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Protein Degradation and Memory
There is currently general agreement about the idea that synaptic plasticity related to
forming new memories requires altered gene expression and de novo protein synthesis in
neurons (Chen & Tonegawa, 1997; Helmstetter, Parsons, & Gafford, 2008; Kandel, 2001). More
recently, attention has shifted to the role of protein degradation through the ubiquitin proteasome
system (UPS) (Ehlers, 2003; Hegde et al., 1997; Mabb & Ehlers, 2010). Within this system,
proteins are tagged with ubiquitin polypeptides and are subsequently degraded by the 26S
proteasome complex, which is comprised of a proteolytic core (20S) and two 19S regulatory
caps (Hegde, 2010). During periods of synaptic activity calcium influx through NMDARs
increases CamKII signaling, which directly activates the proteasome by phosphorylating serine
120 on the RPT6 subunit of the 19S cap (Jarome, Kwapis, Ruenzel, & Helmstetter, 2013). This
phosphorylation activates the proteasome in an ATP-dependent manner, and allows for the 26S
complex to deubiquitinate, unfold, and degrade substrates (Jarome & Helmstetter, 2013).
Once the proteasome complex is activated, it contributes to synaptic destabilization
which is critical for the consolidation of new memories and following the retrieval of old ones
(Lee et al., 2008). Known targets of the UPS that contribute to synaptic destabilization include
AMPAR-associated scaffolding proteins SHANK and GKAP (Hung, Sung, Brito, & Sheng,
2010; Lee et al., 2008). Once degraded, calcium permeable AMPARs can be dissociated from
the post-synaptic density allowing for the insertion of calcium impermeable AMPARs,
ultimately stabilizing long term potentiation and presumably memories (Henley & Wilkinson,
2013).
UPS-mediated proteolysis is required for the synaptic plasticity contributing to the
formation of many different types of memories in structures including the AMY, DH, and PFC
(reviewed in Jarome & Helmstetter, 2013). Within the AMY, fear conditioning leads to increased
lysine 48 (K48)-linked ubiquitin tagging of SHANK and proteins involved in translational
control, as well as increased proteasome activity evidenced chymotrypsin and trypsin-like 20S
activity assays (Jarome et al., 2013; Jarome, Werner, Kwapis, & Helmstetter, 2011). Moreover,
7

post-training inhibition of the proteasome with the compound clasto-Lactacystin ß-lactone (ßlac) impairs long-term memory formation in a manner similar to protein synthesis inhibition. The
upregulation of UPS activity following consolidation occurs following auditory or contextual
memory retrieval as well (Jarome et al., 2011). Interestingly, while inhibition of protein synthesis
following memory retrieval (with anisomycin) normally produces amnesia, this effect can be
rescued via co-inhibition of proteolytic activity – an effect that suggests UPS activity triggers the
need for protein synthesis and directly regulates the destabilization of memory traces.
The UPS-mediated processes in the AMY seem to occur in other brain structures as well.
Inhibitory avoidance training increases ubiquitination of high molecular weight proteins in the
hippocampus four hours after training (Lopez-Salon et al., 2001). In line with this, proteasome
inhibition in the CA1 of DH one hour, four hours, or 7 hours following inhibitory avoidance
training impairs memory. Additionally, following memory retrieval amnestic effects of
anisomycin may be mitigated via co-infusion of a proteasome inhibitor, suggesting there are
conserved mechanisms of plasticity between the AMY and the HPC (Lee et al., 2008). Similar to
the AMY and HPC, Reis and colleagues (2013) found that UPS involvement in mnemonic
processes is not limited to subcortical structures, as proteolysis in the PFC is critical for trace
fear memory formation. Following TFC, the PFC displays increased ubiquitination on a similar
time scale as that of the AMY (Reis et al., 2013).
With regard to contributions of the UPS to the plasticity required for TFC in particular,
there is only one investigation published to date Reis and colleagues (2013). However, given the
previously documented role of the AMY and the HPC in TFC, it is likely that UPS-mediated
degradation contributes TFC in these structures (reviewed in Jarome & Helmstetter, 2014).
Additionally, pilot data from an experiment wherein ß-lac was infused into the AMY of F344
rats prior to TFC suggests that amygdalar UPS activity is necessary for learning in the trace
procedure as well (Figure 1). There was no difference in pre-training freezing between the two
groups (t=0.436 df=7, p=0.67), and there was a modest, but significant, increase in post-training
freezing in animals that received ß-lac (t=2.515 df=7, p=0.04; Figure 1a). Proteasome inhibition
8

impaired memory formation as evidenced by a reduction in freezing at retrieval during the
average of the two CS presentations (t=2.139 df=7, p=0.06), during the average of the two TIs
(t=3.727 df=7, p<0.01), and during the average of the two ITIs (t=5.391 df=7, p<0.01; Figure
1b). Thus, it seems that neurons within these brain structures that are critical to TFC undergo
plastic changes during learning, and these cell-level changes depend on the UPS.

Age-related Changes in UPS Activity
One of the hallmarks of aging is a loss of proteostasis, or an imbalance in the interplay
between protein synthesis and protein degradation (López-Otín, Blasco, Partridge, Serrano, &
Kroemer, 2013; Martinez-Vicente, Sovak, & Cuervo, 2005; Saez & Vilchez, 2014). This
imbalance, initially reviewed more than 30 years ago, usually tips towards an age-related
decrease in clearance of damaged, misfolded, or normally short-lived proteins resulting in their
accumulation (Ding & Zhu, 2015; Löw, 2011; Makrides, 1983). Age-related decreases in basal,
or homeostatic, proteasome activity have been characterized in a number of bodily tissues
including adipose, kidney, liver, heart, and lung (Baraibar & Friguet, 2012; Keller, Hanni, &
Markesbery, 2000). These decreases in basal proteasome activity are not limited to somatic
tissues; they also manifest in aging areas of the central nervous system including the cerebral
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cortex, HPC, spinal cord, and cerebellum (Chondrogianni, Sakellari, Lefaki, Papaevgeniou, &
Gonos, 2014; Chondrogianni et al., 2015; Giannini et al., 2013; Keller et al., 2000).
There is much debate regarding whether the activity of 20S or 26S proteasome
complexes is reduced independently from the capacity for degradation. Some work from
Giannini and colleagues (2013) suggests that, in Sprague Dawley rats, aged 20S and 26S
proteasomes may be decreased in their activity when quantified via fluorogenic substrate
degradation (e.g. chymotrypsin [Suc-LLVY-AMC] or trypsin [Bz-VGR-AMC]), but not when
tested in a way that measures their capacity in requiring the 19S regulatory cap to deubiquitinate
and unfold the substrate prior to degradation. However, it should be noted that the authors of that
study did not sufficiently justify the reduction in aged proteasomal activity they observed when
using the most commonly used proteasome activity assays in the field, and instead focused on
the artificial substrate they designed to be more physiologically relevant. One other investigation
of GFP reporter mice claims no age-related impairment in proteasome function, however the
authors never directly test proteasome activity and instead quantify UPS-related mRNA and
protein levels during aging (Cook et al., 2009). It may be the case that regulation of 20S core
activity, either by means of 19S input or an age-related attenuation of 20S catalytic properties,
underlies the frequently observed loss of proteostasis with increasing age. Indeed, transgenic
mice engineered to display global reduced chymotrypsin proteasome activity have reduced life
spans and develop age-related phenotypes suggesting that an age-related reduction in proteasome
activity is likely involved in cellular and organismal senescence (Tomaru et al., 2012).
While substantial evidence exists for a reduction in homeostatic proteasome activity in
the central nervous system with increasing age, no studies to date have investigated age-related
changes in UPS function contributing to the synaptic plasticity underlying learning and memory,
also known as activity-related UPS activity. If the deficits in basal proteolysis extend into
activity-dependent proteolysis, then age-related impairments in UPS function could be
responsible for memory decline during normal aging. In order to directly test this, we trained
young (3 months) and aged (22 months) F344 rats in TFC and brought them back for a retrieval
10

session the following day. The two age groups showed no differences in freezing during the
training session either before (t=0.1974 df=18, p=0.84) or after the tone-shock pairings (t=0.1845
df=18, p=0.85; Figure 2a). At retrieval, however, aged rats showed reduced CS freezing (t=2.678
df=18, p=0.02), TI freezing (t=9.246 df=18, p<0.01), and ITI freezing (t=6.968 df=18, p<0.01;
Figure 2b). All rats were sacrificed 90 minutes following TFC retrieval for western blot analysis
of activity-related UPS function, as this time point has been shown to maximally activate the
UPS following auditory memory retrieval (Jarome et al., 2011). The amygdala and dorsal
hippocampus were dissected and crude synaptosomal fractions were obtained from both
structures as previously described (Jarome et al., 2011). Within the amygdala, western blotting
revealed decreased levels of phosphorylated RPT6 at Serine 120 (t=2.381 df=17, p=0.02; Figure
2c), no differences in total RPT6 (t=2.002 df=17, p=0.06; Figure 2d), increased K48-linked
ubiquitin levels (t=2.305 df=17, p=0.03; Figure 2e), and no differences in total actin (t=1.642
df=17, p=0.12; Figure 2f). This pattern of decreased UPS activation in aged rats following
memory retrieval was also present in synapses of the dorsal HPC, where we observed decreased
phosphorylated RPT6 (t=2.028 df=17, p=0.05; Figure 2g), no differences in total RPT6
(t=0.0076 df=17, p=0.99; Figure 2h), increased levels of K48-linked ubiquitin (t=2.704 df=17,

p=0.01; Figure 2i), and no differences in actin (t=1.17 df=17, p=0.25; Figure 2j). These results
suggest decreased activation of the UPS following memory retrieval, evidenced by decreased
phosphorylated RPT6 and decreased clearance of K48-linked ubiquitin, accompany the agerelated memory deficit observed in aged rats. Thus, stimulation of this activity-dependent UPS
activity underlying memory formation and retrieval may serve as a novel and therapeutic way to
treat cognitive decline in normal aging.
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Methylene Blue and Proteasome Activity Upregulation
One potential way of stimulating proteasome activity, and rescuing the aforementioned
age-related decline, is via methylthioninium chloride or methylene blue (MB), administration
(Medina, Caccamo, & Oddo, 2011). MB is an FDA-grandfathered tricyclic phenothiazine that
was first synthesized in 1876 as a textile dye, and has since been used as a redox indicator in
chemical reactions, a supravital/neuroanatomical stain, and a cancer chemotherapy agent (Peter,
Hongwan, Kupfer, & Lauterburg, 2000; Wainwright & Crossley, 2002). Additionally, MB is
effective in treating disorders ranging from methemoglobinemia, urinary tract infections,
malaria, mental disorders (e.g. schizophrenia), and hypoxic effects on the central nervous system
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resulting from cardiac arrest (Bruchey & Gonzalez-Lima, 2008; Howland, 2016; Oz, Lorke,
Hasan, & Petroianu, 2010; Schirmer, Adler, Pickhardt, & Mandelkow, 2011).
A large portion of MB’s therapeutic effects can be attributed to its unique auto-oxidizable
properties conferred by the presence of a thiazine ring system and an imine group (Wainwright
& Crossley, 2002). The thiazine ring system allows for a high reduction potential in the presence
of oxygen, while the imine group confers antioxidant properties. Combined, these functional
groups allow MB to participate in electron cycling without incurring any lasting changes in its
net reduction (Schirmer et al., 2011). This participation in electron cycling allows MB to aid in
aerobic respiration, particularly during periods of increased bioenergetic demands, stress, or
disease (Rojas, Bruchey, & Gonzalez-Lima, 2012).
Medina and colleagues (2011) administered MB to 3xTg-AD transgenic mice, which
develop age-related accumulation of Aß and tau and cognitive decline, for four months in their
diet. Twenty-five milligrams of MB was mixed with every 100 milligrams of food powder, and
the mice had access to food ad libitum. Unfortunately, this method lacks specificity in terms of
dosage, but Rojas and colleagues (2012) calculated an approximate dose of 30mg/kg in this
experiment. Nonetheless, MB treatment successfully prevented the strain-associated decline in
performance on the spatial reference version of the Morris water maze task. Additionally, MB
treatment reduced the accumulation of Aß, but not hyper-phosphorylated tau. While previous
work suggests MB upregulates mitochondrial function, four months of dietary MB
administration does not affect mitochondrial function in any way (Bruchey & Gonzalez-Lima,
2008; Medina et al., 2011). MB treatment did not alter amyloid precursor protein processing
either, which lead the authors to hypothesize that MB-mediated prevention of Aß accumulation
must occur after Aß has been produced, directly implicating the UPS in clearance of Aß.
Interestingly, mice that were administered MB displayed higher levels of trypsin-like and
chymotrypsin-like, but not caspase-like, 20S proteasome activity in whole brain homogenates
(Medina et al., 2011). Thus, dietary MB administration significantly upregulates two of the three
types of proteasome activity that are inherent to the UPS, and could possibly rescue the deficits
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reported in Figure 2, although the brain structures and cellular compartments in which
proteasome activity is upregulated remain to be elucidated.
While there is only one study to date on MB and proteasome upregulation, a number of
other investigations have demonstrated a role for MB in enhancing mitochondrial function and
general memory performance (reviewed in Rojas et al., 2012). Collectively, these studies
revealed that MB displays hormetic properties wherein very low doses do not affect cellular or
behavioral processes and high doses actually produce deficits in mitochondrial function and
behavior. The vast majority of these investigations employed acute intraperitoneal (IP) MB
administration. The first investigation to document MB-mediated memory enhancement showed
a 1mg/kg IP injection immediately after inhibitory avoidance conditioning enhances retention of
the avoidance memory (Martinez, Jensen, & Vasquez, 1978). A number of other studies show
acute and low (i.e. 1-4mg/kg) doses of MB enhance memory in holeboard spatial search
appetitive tasks, conditioned fear extinction, object recognition, open field habituation, and
discrimination learning (Callaway, Riha, Bruchey, Munshi, & Gonzalez-Lima, 2004; Callaway,
Riha, Wrubel, McCollum, & Gonzalez-Lima, 2002; Gonzalez-Lima & Bruchey, 2004; Riha,
Bruchey, Echevarria, & Gonzalez-Lima, 2005; Riha, Rojas, & Gonzalez-Lima, 2011; Telch et
al., 2014; Wrubel, Barrett, Shumake, Johnson, & Gonzalez-Lima, 2007a; Wrubel, Riha,
Maldonado, McCollum, & Gonzalez-Lima, 2007b).
The acute and low dose manipulations that improve memory performance reliably
upregulate cytochrome oxidase activity, and have contributed to the idea that MB participates in
electron shuttling within the mitochondria and aids in upregulating the aerobic capacity of active
neurons (Rojas et al., 2012). Unfortunately, no study to date has investigated the effects of acute,
low dose MB on UPS function and it is possible that the field may have overlooked an additional
effector for MBs unique memory enhancing properties. Indeed, there exists substantial interplay
between the mitochondria and the UPS, wherein the UPS serves as a quality control mechanism
for mitochondrial health especially in aging and disease (Lehmann, Udasin, & Ciechanover,
2016; Livnat-Levanon & Glickman, 2011; Ross, Olson, & Coppotelli, 2015). Thus, an
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interaction between these two organelles when MB is administered at low doses still needs to be
investigated.
Summary and Aims
An age-related decline in episodic memory performance in humans is evident, and this is
analogous to the decline in TFC performance observed in aged rodents. While the UPS normally
functions to aid in the formation and consolidation of memory, preliminary data suggests agerelated aberrant UPS processing following memory retrieval. Moreover, preventing UPS activity
in young rats mimics deficits observed in aged rats in TFC. The compound MB offers a novel
and potentially therapeutic means to rescue age-related proteasome dysfunction, and
subsequently abolish age-related impairments in TFC. Thus, the overarching aim of the present
thesis was to address whether MB administration could improve memory in young rats and
rescue memory impairments in aged rats via upregulation of activity-related UPS activity.
Specific aims included determining age-appropriate intraperitoneal dosages of MB for peak
proteasome activity upregulation and memory enhancement (Aim 1) and to use MB in a more
translational and chronic dietary approach to enhance memory performance and prevent agerelated cognitive decline (Aim 2). In Aim 1, it was predicted that aged rats would require a
higher acute dose of MB (4 mg/kg) in order to stimulate UPS activity and rescue age-related
memory impairments, and that young rats would require a lower dose of MB (1 mg/kg) for
memory enhancement and UPS upregulation. In Aim 2, it was predicted that chronic dietary
administration of MB would enhance memory and UPS function in young rats, and that aged rats
receiving the MB diet would display enhanced memory and UPS function relative to aged rats
receiving the control diet.

MATERIALS & METHODS

Subjects. Subjects were 100 male F344 rats obtained from Charles River (Raleigh, NC). Aim 1
consisted of 64 animals, 32 of them were 3 months old and 32 of them were 22 months old at the
time of delivery. One aged rat died of natural causes after training but before retrieval, and thus
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produced no data. Aim 2 consisted of 36 animals, 18 of them were 3 months old and 18 of them
were 18 months old at the time of delivery. Two aged rats died of natural causes during the fourmonth feeding period and thus no data was gathered from them. Animals were housed
individually in shoebox cages with food and water available ad libitum. The colony room was
maintained under a 14:10 hour light/dark cycle. The University of Wisconsin-Milwaukee
Institutional Animal Care and Use Committee approved all procedures prior to commencement
of experimentation.

Conditioning Apparatus. Fear conditioning occurred in a set of four identical chambers (Context
A). The floor of Context A was composed of stainless steel rods through which footshocks were
delivered. Each chamber was illuminated by an overhead incandescent bulb and was connected
to its own shock generator-scrambler (Coulbourn, Whitehall, PA). Ventilation fans provided
constant background noise (~60 dB). Chambers in Context A were cleaned with a solution of 5%
ammonium hydroxide between animals. A second set of chambers (Context B) was used to
conduct auditory CS testing. Context B differed from Context A in a number of ways, including
infrared lighting, a solid and opaque textured floor panel, and a different cleaning solution (5%
acetic acid).

Behavioral Procedures. All animals were handled for three days prior to behavioral
manipulation. This consisted of transport to the behavior room and gentle restraint in a towel.
Fear conditioning was conducted in Context A while auditory CS testing was conducted in
Context B. All animals were trace fear conditioned on day 1 with 10 CS-US pairings. The CS
was a 10s white noise cue (72 dB) and the UCS was a 1s footshock (0.5 mA). Note: the weaker
shock used in this paradigm was chosen to be sensitive to behavioral enhancements in freezing
stemming from MB treatment. The CS and UCS were separated by an empty 30s trace interval,
and CS-USC pairings were separated by an ITI of six minutes. One day following conditioning,
rats received underwent a retrieval session consisting of two 15s CS presentations following a 2
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minute baseline period. The two CS’s were separated by 175 seconds allowing for measurement
of freezing behavior.

Methylene Blue Administration. In Aim 1, USP-grade MB (Sciencelab.com, Houston, TX) was
dissolved in 0.9% saline to create two stock concentrations, one at 2mg/ml and one at 10mg/ml.
Rats were weighed the night before behavioral manipulations/injections and received the
appropriate volume of MB solution corresponding to dosages of 1, 2, 4, and 16 mg/kg injected
IP. Control rats in both age groups received a similar amount of saline as rats in other conditions
(0.5mL) to control for volume of IP injections. In Aim 2, control rat chow was ground into a
fine powder using a food processor and 2g of sucrose was added per 100g of food powder. The
experimental rat chow was prepared in a similar manner, except 25mg of USP-grade MB was
added per 100g of control diet. The control and experimental diets were placed in feeding dishes
in rat cages and replaced every other day during the four-month feeding period.

Conditional Fear Responses. In all cases, the average percent time spent freezing was calculated
using the FreezeScan 1.0 software (CleverSys, Reston, VA). In Aim 1, two-way ANOVAs (Dose
x Age) were used to compare group means within each behavioral epoch analyzed (i.e. baseline,
CS, TI, ITI). In Aim 2, two-way ANOVAs (Diet x Age) were used to compare group means
within each behavioral epoch analyzed (i.e. baseline, CS, TI, ITI). In both aims, Dunnett’s
method was used to perform post-hoc comparisons of each group to the 3-month control group
(Aim 1-control diet, Aim 2-0mg/kg MB) if the interaction term was significant (p<0.05).

Crude Synaptosomal Membrane Fractionation. Animals were sacrificed with an overdose of
isoflurane. This occurred 90 minutes following TFC retrieval in all experiments. Brains were
rapidly removed and flash frozen on dry ice. Using a rat brain matrix (Harvard Apparatus, MA)
incubated on dry ice, structures of interest were dissected from the brains. Synaptosomal
membrane fractions were obtained using methods previously described, but with minor
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alterations (Jarome et al., 2011). Tissue samples were homogenized in TEVP buffer with 320
mM Sucrose and centrifuged at 1000 x g for 10-minutes at 4°C. The supernatant was collected
and spun at 10,000 x g for 10-minutes at 4°C. The resulting pellet, containing the synaptosomal
fraction, was resuspended in phospho-homogenization buffer (50 mM Tris-HCl, 6 mM sodium
deoxycholate, 150 mM NaCl, 1mM NaF, two mini EDTA-free cOmplete protease inhibitor
tablets (Roche), 0.1% SDS, 1 mM sodium orthovanadate) and measured using a 660nm protein
assay (Pierce).

20S Proteasome Activity Assay. Brains were removed, frozen on dry ice, and stored at -80°C
until use. Following dissection, synaptic fractionation, and protein measurement 10μg of sample
was diluted in distilled water. Diluted samples were then mixed with reaction buffer (250 mM
HEPES, pH 7.5, 5 mM EDTA, 0.5% NP-40, 0.01% SDS, 20 mM ATP). The fluorogenic
peptides LLVY-AMC (Millipore, MA) and Bz-VGR-AMC (Enzo Life Sciences) were added to
samples to assess chymotrypsin-like and trypsin-like activities of the proteasome complex.
Reactions were incubated at 37°C for two hours and fluorescence was recorded every five
minutes in a 96-well microplate reader (Synergy H1; Biotek, VA) at 360nm/460nm. Protein-free
blanks were used to assess auto-hydrolysis of flourogenic peptides and activity was determined
via interpolation to an AMC standard curve produced following manufacturer instructions. The
normalized 20S activity assay data was then analyzed using two-way ANOVAs (Dose x Age in
Aim 1, and Diet x Age in Aim 2). In both aims, Dunnett’s method was used to perform post-hoc
comparisons of each group to the 3-month control group (Aim 1-control diet, Aim 2-0mg/kg
MB) only if the interaction term was significant (p<0.05).

Procedure: Aim 1. Male F344 rats aged 3 and 22 months were administered 0, 1, 2, 4, or 16
mg/kg of MB IP immediately after TFC. Twenty-four hours later, all rats underwent memory
retrieval and were sacrificed 90 minutes following the retrieval session. Brains were collected
and the PFC, AMY, DH, and RSC were dissected. After which, samples underwent
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synaptosomal fractioning and subsequent trypsin-like and chymotrypsin-like 20S proteasome
activity assays to measure raw UPS activation resulting from MB treatment and memory
retrieval. Multiple doses of MB were used in order to determine the optimal MB dose for both
UPS activation as well as for memory enhancement in acute procedures commonly employed in
the field.

Procedure: Aim 2. This experiment attempted to recapitulate the findings from Medina and
colleagues (2011) in order to determine if their effects extend to F344 rats and to determine in
which brain structures and neuronal compartments proteasome activity is upregulated following
dietary treatment with methylene blue. Male F344 rats aged 3 and 18 months were administered
a control diet or a diet consisting of 25mg of MB per 100 grams of food powder for four months.
After four months, all rats were trained in TFC procedures and underwent memory retrieval 24
hours after conditioning. Ninety minutes following retrieval, rats were sacrificed and brains were
collected. The PFC, AMY, DH, and RSC were dissected and samples underwent crude
synaptosomal fractionation prior to trypsin-like and chymotrypsin-like 20S proteasome activity
assays. The aim of these procedures was to extend findings previously documented by Medina
and colleagues, and importantly, to give better resolution into the effects of dietary
administration of MB on memory performance and proteasome activity upregulation in both
young and aged rats.
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RESULTS
Aim 1

Behavior

Rats aged 3 months (n=32) or 22 months (n=31) were split into groups to receive 0, 1, 4,
or 16mg/kg MB IP immediately following TFC. All groups had eight subjects per group except
for the 22-month 4mg/kg group, which had seven subjects. All rats were trained in TFC. During
the baseline epoch of training there was a main effect of age on freezing behavior in that aged
rats froze significantly higher than young animals (F (1,55)=11.22, p<0.01; Figure 3a-b).
However, during the last TI of training there were no differences in freezing between young and
aged rats (F (1,55)=0.156, p=0.69; Figure 3a-b). Thus, both age groups behaved similarly at the
end of training, and there were no age-related deficits in displaying freezing behavior that could
obfuscate interpretation of freezing behavior at retrieval. Main effects of dose and interaction
terms were not examined as IP MB administration occurred post-training.
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In order to determine the age- and dose-dependent effects of IP MB administration
immediately following TFC on subsequent memory performance, all rats underwent memory
retrieval 24 hours after training. During the baseline epoch of retrieval, there was a main effect of
age on freezing behavior in that aged rats froze significantly less (F (1, 55)=7.911, p<0.01;
Figure 3c-d). There was no main effect of dose of MB on freezing behavior (F (3, 55)=0.6376,

p=0.59; Figure 3c-d), and no interaction between dose and age (F (3, 55)=1.79, p=0.16; Figure
3c-d). Average freezing during the CS presentations at retrieval was lower in aged animals (F (1,
55)=9, p<0.01; Figure 3c-d), but there was no effect of MB dose (F (3, 55)=1.834, p=0.15;
Figure 3c-d) and no interaction (F (3, 55)=0.2098, p=0.89; Figure 3c-d). Additionally, aged rats
froze significantly less than young rats during the two TIs (F (1, 55)=13.51, p<0.001; Figure 3cd), but there was no effect of MB dose (F (3, 55)=0.5744, p=0.63; Figure 3c-d) and no
interaction (F (3, 55)=0.5402, p=0.66; Figure 3c-d). Finally, freezing during the ITIs of retrieval
was lower in aged rats regardless of MB dose (F (1, 55)=11.95, p<0.01; Figure 3c-d). However,
there was no effect of dose on memory performance (F (3, 55)=0.5612, p=0.64; Figure 3c-d) and
no interaction between age and MB dose (F (3, 55)=0.7813, p=0.51; Figure 3c-d).
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20S Activity Assays

In order to determine age- and MB dose-dependent differences in plasticity-associated
20S activity, tissue was collected 90 minutes post-retrieval. Chymotrypsin-like and trypsin-like
20S activities were measured in synaptic and cytosolic fractions from the PFC, RSC, DH, and
AMY (Figures 4 and 5).
Chymotrypsin-like activity was not consistently upregulated after memory retrieval in
response to post-training MB administration (Figure 4). In the synaptic fraction of the PFC there
was no main effect of MB dose (F (3,55)=0.5944, p=0.62; Figure 4a), age (F (1,55)=0.3783,

p=0.54; Figure 4a), or interaction between the two (F (3,55)=0.7712, p=0.51; Figure 4a). Aged
rats displayed less chymotrypsin-like 20S activity in the cytosolic fraction of the PFC (F
(1,55)=13.77, p<0.001; Figure 4e), but there was no effect of MB dose (F (3,55)=1.631, p=0.19;
Figure 4e), or an interaction (F (3,55)=1.129, p=0.35; Figure 4e).
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In the synaptic fraction of the RSC, there was an age related decrease in chymotrypsinlike activity (F (1,55)=11.05, p<0.01; Figure 4b), a main effect of dose (F (3,55)=5.9, p<0.01;
Figure 4b), and an interaction between dose and age (F (3,55)=7.345, p<0.001; Figure 4b).
Furthermore, 16mg/kg MB seems to maximally upregulate proteasome activity in young animals
and this group was significantly higher than the 0mg/kg 3-month group (p<0.001). In the
cytosolic fraction of the RSC, there was an age-related reduction in chymotrypsin-like activity
independent of dose (F (1,55)=39.68, p<0.0001; Figure 4f). There was no main effect of MB
dose (F (3,55)=2.729, p=0.052; Figure 4f) and no significant interaction between age and dose (F
(3,55)=1.918, p=0.14; Figure 4f).
Within the DH, MB administration seems to differentially affect chymotrypsin-like 20S
in the synaptic versus the cytosolic cellular compartments. In the synaptic fraction there was a
significant interaction between dose and age (F (3,55)=4.142, p=0.01; Figure 4c). It seems that as
the dose of MB increases, proteasome activity decreases in young animals and increases in aged
animals, although no follow-comparisons of each group to the 0mg/kg 3-month group were
significant. Additionally, there were no main effects of age (F (1,55)=0.1292, p=0.72; Figure 4c)
or dose ((F (3,55)=0.6982, p=0.56; Figure 4c). In contrast, cytosolic chymotrypsin-like activity
changed in an age- and dose-dependent manner. There was a significant interaction between MB
dose and age ((F (3,55)=3.918, p=0.01; Figure 4g), and follow up comparisons revealed that, for
aged animals, as the dose increased chymotrypsin-like activity decreased relative to the 0mg/kg
3-month group (22 month-0mg/kg, p=0.01; 22-month-1mg/kg, p<0.0001; 22-month-4mg/kg,

p<0.0001; 22-month-16mg/kg, p<0.0001; Figure 4g). Additionally, there was a main effect of
age (F (1,55)=130.4, p<0.0001; Figure 4g) and dose (F (3,55)=4.708, p<0.01; Figure 4g),
although these effects are more difficult to interpret given the significant interaction between
them.
There was a dichotomy in the pattern of 20S activation in the AMY between the synaptic
and cytosolic fractions. In the synaptic portion of the AMY, there was an age-related decrease in
20S activity regardless of dose (F (1,55)=7.802, p<0.01; Figure 4d), but no main effect of dose
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(F (3,55)=0.8212, p=0.49; Figure 4d) or interaction (F (3,55)=0.588, p=0.63; Figure 4d). In
contrast, 20S activity in the cytosolic fraction was higher in aged animals regardless of MB dose
((F (1,55)=31.07, p<0.0001; Figure 4h). The main effect of dose approached significance (F
(3,55)=2.53, p=0.067; Figure 4h) and there was no significant interaction (F (3,55)=0.9417,

p=0.43; Figure 4h).

Similar to chymotrypsin-like activity, trypsin-like activity was not consistently
upregulated following memory retrieval in response to post-training MB administration (Figure
5). In the synaptic fraction of the PFC, there was no effect of age (F (1,55)=2.32, p=0.13; Figure
5a), dose (F (3,55)=1.028, p=0.39; Figure 5a), or interaction between them (F (3,55)=0.4575,

p=0.71; Figure 5a). However, in the cytosolic portion of the PFC, dose significantly influenced
trypsin-like activity and higher doses of MB produced less 20S activity regardless of age (F
(3,55)=3.829, p=0.01; Figure 5e). There was no main effect of age (F (1,55)=0.841, p=0.36;
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Figure 5e), or interaction between dose and age (F (3,55)=0.4821, p=0.70; Figure 5e) on 20S
activity.
MB administration greatly affected trypsin-like proteasome activity in the synaptic
fraction of the RSC. An interaction between age and MB dose was evident (F (3,55)=7.297,

p<0.001; Figure 5b), and follow-up comparisons to the 3-month 0mg/kg group revealed that
16mg/kg MB treatment in 3-month animals significantly upregulates 20S activity (p<0.01;
Figure 5b), while 1mg/kg MB treatment in 22-month animals significantly upregulates 20S
activity (p<0.01; Figure 5b). Aside from the interaction, there was a general age related increase
in trypsin-like activity (F (1,55)=15.02, p<0.001; Figure 5b) and a main effect of MB dose (F
(3,55)=3.406, p=0.04; Figure 5b). In the cytosolic portion of the RSC, there was only an agerelated reduction in 20S activity that was independent of MB dose (F (1,55)=47.15, p<0.0001;
Figure 5f), and there was no significant effect of MB dose alone (F (3,55)=1.26, p=0.30; Figure
5f) or an interaction (F (3,55)=1.928, p=0.14; Figure 5f).
Much like chymotrypsin-like activity, a similar pattern of trypsin-like activity emerged in
the DH following MB administration. There were no significant main effects in the synaptic
fraction (age: F (1,55)=1.353, p=0.25; Figure 5c; dose: F (3,55)=1.34, p=0.27; Figure 5c), or an
interaction between them (F (3,55)=2.593, p=0.06; Figure 5c). In contrast, data from the
cytosolic fraction of the DH indicate an age-related reduction (F (1,55)=177.8, p<0.0001; Figure
5g), and dose-related reduction (F (3,55)=7.378, p<0.001; Figure 5g) in trypsin-like 20S activity.
However, because the interaction term was not significant (F (3,55)=2.494, p=0.07; Figure 5g),
follow-up tests were not possible. Nonetheless, it appears that as dose increases, proteasome
activity in the cytosolic fraction of the DH decreases.
Finally, the pattern of trypsin-like proteasome activity in the AMY was the opposite of
that observed for chymotrypsin-like activity. In the synaptic fraction there was a general agerelated increase in 20S activity (F (1,55)=84.71, p<0.0001; Figure 5d), but no effect of dose (F
(3,55)=0.8653, p=0.46; Figure 5d) or interaction (F (3,55)=0.3271, p=0.81; Figure 5d). In stark
contrast, the cytosolic fraction showed an age-related decrease in 20S activity that was
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independent of MB dose (F (1,55)=57, p<0.0001; Figure 5h). However, dose alone (F
(3,55)=2.536, p=0.07; Figure 5h) or an interaction between age and dose (F (3,55)=0.2416,

p=0.87; Figure 5h) did not affect trypsin-like activity in the cytosolic fraction of the DH.

Aim 2

Behavior

Rats aged 3 months (n=18) or 18 months (n=18) were split into groups to receive either a
control diet or an MB-containing diet for a four-month period. All groups had nine subjects per
group except for the 22-month MB group, which had seven subjects. In order to examine the
mnemonic effects of dietary treatment with MB on young and aged rats and to extend the
findings from Medina and colleagues (2011), all rats were trained in TFC at the end of the 4month feeding period. During the baseline epoch of training, there were no effects of age (F
(1,30)=3.681, p=0.06; Figure 6a), diet (F (1,30)=0.0396, p=0.84; Figure 6a), and no age by diet
interaction (F (1,30)=0.0005, p=0.98; Figure 6a). Importantly, there were also no differences
between groups in freezing during the last TI of training as a function of age (F (1,30)=1.477,

p=0.23; Figure 6a), diet (F (1,30)=0.0475, p=0.82; Figure 6a), or an interaction between the two
(F (1,30)=0.6396, p=0.43; Figure 6a). Thus, it can be concluded that there were no differences in
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acquisition of freezing behavior between age groups or diet condition during training that may
confound freezing behavior analysis at retrieval.
All rats underwent memory retrieval 24 hours post training in order to examine the
effects of dietary MB administration on learning and memory processes. During the baseline
period of retrieval there was no main effect of age (F (1,30)=0.2518, p=0.62; Figure 6b), diet (F
(1,30)=0.0191, p=0.89; Figure 6b), or an interaction (F (1,30)=1.696, p=0.20; Figure 6b) on
freezing behavior. Similarly, freezing behavior averaged across the two CS presentations did not
differ as a function of age (F (1,30)=0.0103, p=0.92; Figure 6b), diet (F (1,30)=2.771, p=0.11;
Figure 6b), or an interaction between the two (F (1,30)=2.471, p=0.13; Figure 6b). However,
average freezing during the two TIs was lower in aged animals regardless of diet (F
(1,30)=7.117, p=0.01; Figure 6b). Diet type did not influence TI freezing (F (1,30)=2.49, p=0.13;
Figure 6b) and there was no significant interaction between age and diet (F (1,30)=0.8256,

p=0.37; Figure 6b). ITI freezing was also lower in aged rats regardless of diet type (F
(1,30)=13.85, p<0.001; Figure 6b), but there was no effect of diet independent of age (F
(1,30)=2.764, p=0.11; Figure 6b) or significant interaction (F (1,30)=0.2739, p=0.60; Figure 6b).
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20S Activity Assays

In order to examine the effects of four months of dietary MB administration on plasticityassociated 20S proteasome activity in young and aged rats, brain tissue was collected 90 minutes
post-retrieval. Chymotrypsin-like and trypsin-like 20S activities were measured in synaptic and
cytosolic fractions from the PFC, RSC, DH, and AMY (Figures 7 and 8).
In a manner much similar to IP MB administration in Aim 1, dietary administration of
MB did not consistently upregulate 20S proteasome activity throughout the brain regions and
cellular compartments investigated. Dietary treatment with MB significantly upregulated
chymotrypsin-like activity in the synaptic fraction of the PFC (F (1,30)=5.111, p=0.03; Figure
7a), but there was no main effect of age (F (1,30)=0.0797, p=0.78; Figure 7a) or an interaction
between the two (F (1,30)=0.106, p=0.75; Figure 7a). In contrast, the cytosolic fraction of the
PFC showed an interaction effect between diet and age on chymotrypsin-like activity (F
(1,30)=6.834, p=0.014; Figure 7e), and follow up tests revealed that MB treatment in young
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animals significantly reduces 20S activity (p<0.01; Figure 7e). Additionally, there were main
effects of age (F (1,30)=4.697, p=0.04; Figure 7e) and diet (F (1,30)=7.821, p<0.01; Figure 7e),
but these are likely driven by the sharp decrease in proteasome activity in young animals that
received the MB-containing diet.
The pattern of chymotrypsin-like 20S activity in the RSC was different between the
synaptic and cytosolic fractions. Animals that received the MB-containing diet showed higher
chymotrypsin-like activity in the synaptic fraction of the RSC regardless of age (F (1,30)=34.47,

p<0.0001; Figure 7b). There was, however, no age-related change in activity (F (1,30)=0.2983,
p=0.59; Figure 7b) or interaction between age and diet (F (1,30)=1.161, p=0.29; Figure 7b). In
the cytosolic fraction of the RSC there was an interaction between the effects of age and diet on
chymotrypsin like activity (F (1,30)=8.293, p<0.01; Figure 7f), and follow up tests showed a
significant reduction in the 22-month MB group relative to the 3-month control group (p<0.01;
Figure7f). There was no main effect of age (F (1,30)=0.1761, p=0.68; Figure 7f), but there was a
main effect of diet (F (1,30)=17.94, p<0.001; Figure 7f) that was likely driven by the sharp
decrease in proteasome activity in the MB treated aged animals.
Dietary treatment with MB did not affect chymotrypsin-like 20S activity in the synaptic
fraction of the DH. There was no main effect of diet (F (1,30)=1.301, p=0.26; Figure 7c), age (F
(1,30)=1.665, p=0.21; Figure 7c), or an interaction between them (F (1,30)=0.0045, p=0.95;
Figure 7c). In contrast, MB treatment significantly increased proteasome activity in the cytosolic
fraction of the DH regardless of age (F (1,30)=17.08, p<0.001; Figure 7g). There was no main
effect of age on 20S activity (F (1,30)=0.0273, p=0.87; Figure 7g), but there was an interaction
between diet and age (F (1,30)=4.82, p=0.04; Figure 7g). Dunnett’s follow up comparisons to the
3-month MB group showed significant increases in the 3-month MB group (p<0.001; Figure 7g)
and the 22-month MB group (p=0.02; Figure 7g).
Tissue from the AMY, regardless of the cellular compartment, did not show any agerelated or diet-related changes in chymotrypsin-like activity. In the synaptic fraction there was no
effect of diet (F (1,30)=1.836, p=0.19; Figure 7d), age (F (1,30)=2.939, p=0.10; Figure 7d), or
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age by diet interaction (F (1,30)<0.0001, p=0.99; Figure 7d). Similarly, in the cytosolic fraction
of the AMY there was no main effect of diet (F (1,30)=1.095, p=0.30; Figure 7h), age (F
(1,30)=0.4088, p=0.53; Figure 7h), or interaction between them (F (1,30)=2.216, p=0.15; Figure
7h) on chymotrypsin-like 20S activity.

Similar to chymotrypsin-like activity, trypsin-like activity was not consistently
upregulated following memory retrieval in response to four months of dietary MB administration
(Figure 8). In the synaptic fraction of the PFC, there was no effect of diet (F (1,30)=0.0154,

p=0.90; Figure 8a), age (F (1,30)=1.194, p=0.28; Figure 8a), or an interaction between them (F
(1,30)=0.1148, p=0.74; Figure 8a) on 20S activity. In contrast, tissue from the cytosolic fraction
of the PFC showed MB diet-related increases in trypsin-like activity (F (1,30)=7.778, p<0.01;
Figure 8e). Age did not significantly affect 20S activity (F (1,30)=0.0584, p=0.81; Figure 8e),
and there was not an interaction between diet and age (F (1,30)=0.1978, p=0.66; Figure 8e).
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Patterns in trypsin-like 20S activity were not consistent between the synaptic and
cytosolic cellular compartments of the RSC. In the synaptic fraction dietary MB significantly
upregulated proteasome activity (F (1,30)=11.43, p<0.01; Figure 8b), while age (F
(1,30)=0.5833, p=0.45; Figure 8b), or an interaction between age and diet (F (1,30)=1.531,

p=0.23; Figure 8b) did not. Tissue from the cytosolic fraction of the RSC showed clear agerelated decreases (F (1,30)=8.622, p<0.01; Figure 8f) that were independent of dietary treatment
(F (1,30)=0.1516, p=0.70; Figure 8f) or an age by diet interaction (F (1,30)=3.177, p=0.08;
Figure 8f).
Dietary treatment with MB has opposite effects on trypsin-like proteasome activity in the
synaptic and cytosolic fractions of the DH. In the synaptic fraction, MB treatment produced a
modest reduction in 20S activity that did not quite reach significance (F (1,30)=3.806, p=0.06;
Figure 8c). However, age (F (1,30)=0.0054, p=0.94; Figure 8c) or an interaction between diet
and age (F (1,30)=0.3884, p=0.54; Figure 8c) had no significant effect on proteolysis. In an
opposite pattern, MB treatment increased proteolysis in the cytosolic fraction of the RSC (F
(1,30)=9.702, p<0.01; Figure 8g). There were no significant effects of age (F (1,30)=1.67,

p=0.21; Figure 8g) or a Diet x Age interaction (F (1,30)=0.1705, p=0.68; Figure 8g).
In the synaptic fraction of tissue from the AMY, dietary MB treatment significantly
reduced trypsin-like 20S activity (F (1,30)=17.41, p<0.001; Figure 8d). Additionally, there was
an age-related reduction in proteolysis regardless of diet type (F (1,30)=15.2, p<0.001; Figure
8d), but there was no interaction between dietary and age-related effects (F (1,30)=0.0041,

p=0.94; Figure 8d). Contrastingly, the MB-containing diet had no effect on 20S activity in
cytosolic 20S activity in the AMY (F (1,30)=0.0005, p=0.99; Figure 8h). There was, however, an
age-related reduction in trypsin-like activity that was independent of diet type (F (1,30)=11.79,

p<0.01; Figure 8d), but the interaction term was not significant (F (1,30)=1.532, p=0.23; Figure
8d).
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DISCUSSION
Acute MB administration immediately post-training at doses of 1, 4, or 16mg/kg had no
effect on subsequent memory performance at retrieval in young or aged rats. There was no clear
MB effect in any of the analyzed epochs, which was unexpected given that we administered
doses of MB that extended throughout its hormetic curve (Rojas et al., 2012). Our lack of an
enhancement in young animals given 1mg/kg IP is in contrast to previously published memory
enhancements with 1mg/kg of MB given IP to adult rats immediately post-inhibitory avoidance
training (Martinez et al., 1978). Additionally, MB doses above 10mg/kg are known to exert
deleterious effects on memory performance (for review see Rojas et al., 2012). However, we did
not see decreased freezing in young or aged animals that received 16mg/kg. The lack of memory
enhancement or impairment cannot be attributed to general performance deficits between groups,
as all groups behaved similarly at the beginning and end of training (i.e. all rats displayed
elevated freezing behavior over time). It is possible that memory enhancing effects of MB do not
extend to TFC procedures, and may not extend to fear conditioning in general (Rojas et al.,
2012). It is true that no study to date has reported MB-driven enhancement of classical auditory
fear conditioning, and the majority of MB enhancements are in fear extinction retention,
decreased fear renewal after extinction, better performance in spatial tasks, or better performance
in object recognition tasks (Rojas et al., 2012).
Although there were no effects of acute MB administration on freezing behavior during
retrieval in either age group, we did replicate our preliminary finding of an age-related deficit in
TFC. Aged rats froze significantly less than young rats during all analyzed epochs of retrieval,
and these results are congruent with previously published age-related deficits in TFC (Moyer &
Brown, 2006; Villarreal et al., 2004).
The lack of a behavioral enhancement with IP MB administration makes the
interpretation of post-retrieval 20S activity less meaningful. However, there were a few patterns
of MB-driven upregulation of 20S activity that were conserved between the types of proteasome
activity examined. Together, it appears the most consistent effects of post-training IP MB
32

administration on proteasome activity measured post-retrieval are in the synaptic fraction of the
RSC and the cytosolic fraction of the DH. In synapses of the RSC, 16mg/kg seems to
consistently upregulate general 20S (i.e. chymotrypsin- and trypsin-like) activity in young
animals, whereas 1mg/kg upregulates general proteasome activity in aged animals. In the
cytosolic fraction of the DH, general 20S activity is lower in aged animals and MB treatment
lowers this activity linearly with increasing dose. Apart from these two clear patterns, data from
the PFC and AMY do not show any consistencies between the types of proteasome activity
examined.
Similar to results with acute MB administration, we did not see any memory
enhancement with chronic MB administration. There were no age-related or diet-related
differences in freezing behavior at the beginning or end of training that could have complicated
our interpretation of freezing behavior at retrieval. During retrieval, the only group differences
were age-related reductions in average freezing behavior during the TI and ITI periods. While it
is important that the age-related deficit in TFC was reproduced once again, it is unfortunate that
MB did not enhance memory performance as reported by Medina and colleagues (2011). There
are few potential sources for our lack of replication. There were discrepancies in the type of
memory task used; they saw enhancements in performance on the spatial references version of
the Morris Water Maze, whereas we were seeking enhancements in fear conditioning. As
previously mentioned, no study to date has demonstrated an MB-related enhancement in auditory
fear conditioning and it’s possible that fear conditioning procedures are too robust to observe an
enhancement. It is also possible that enhancements they observed were species and strain
specific; they used 3xTg-AD transgenic mice, whereas we used inbred F344 rats (Medina et al.,
2011). Future work should examine if dietary treatment with MB, at the dose of 25mg per 100
grams of food powder, for four months can enhance spatial memory in non-transgenic rats in
order to situate our results and extend their findings.
The lack of dietary MB-driven memory enhancement makes interpreting post-retrieval
proteasome activity more difficult. We did not replicate the previously published global
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upregulation in 20S activity in animals that received the MB-containing diet (Medina et al.,
2011). They measured 20S activity in whole brain homogenates, whereas we had structural and
cellular compartmental resolution. It is possible that by isolating certain brain structures, we may
have overlooked other brain regions that drove their observed global increase. However, chronic
MB administration did increase 20S activity in the synaptic fraction of RSC, much similar to
acute MB administration. MB also increased 20S activity in the cytosolic fraction of DH when
administered chronically, which opposed the reductions in 20S activity observed with acute MB
administration. Nonetheless, given that learning during TFC procedures is dependent on the RSC
and DH, it is unclear why upregulating proteasome activity in these structures did not enhance
memory (Kwapis et al., 2015; McEchron, Bouwmeester, Tseng, Weiss, & Disterhoft, 1998).
While there is evidence for proteasome activity in the DH being involved in CFC, no studies to
date have investigated the role of the UPS in either the RSC or the DH during TFC (Lee et al.,
2008). Though unlikely, it is possible that these structures do not depend on UPS function in
TFC procedures.
Another possibility is proteasome upregulation does not necessarily correlate with better
learning, and that previously documented memory enhancements with MB were attributable to
enhanced mitochondrial function (Rojas et al., 2012). If this were true, MB should have affected
electron transport in mitochondria, and resulted in some measurable change in behavior. By
administering MB acutely at doses that cover the hormetic curve, and chronically at a ~30mg/kg
dose known to be harmful to mitochondria, we should have either positively or negatively
impacted cellular respiration. The lack of any change in behavior, positive or negative, suggests
that the changes caused by MB (whether they be on proteolysis or cellular respiration) do not
affect learning and memory processes in TFC.
Given that we have a clear age-related reduction in UPS activity following trace fear
memory retrieval (Figure 2), work towards stimulating UPS activity should continue. Our results
suggest that MB may not be well suited for rescue of age-related cognitive decline via
proteasome activity upregulation. Another promising option for upregulating proteasome activity
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is proteasome-activating peptide 1 (PAP1). PAP1 incubation in cell cultures from C. elegans and

H. sapiens increases chymotrypsin-like proteasome activity (Vechio, Cerqueira, Augusto, Lopes,
& Demasi, 2014). Additionally PAP1 confers resistance to oxidative stress, and attenuates
protein accumulation in a cellular model of amyotrophic lateral sclerosis (Vechio et al., 2014).
PAP1 could be locally infused into structures critical for TFC and could counteract the agerelated decline in UPS function, ultimately rescuing age-related cognitive decline. Nonetheless,
findings reported here rule out MB as a promising option and allow for advancement of the field
towards more promising therapeutic options.

35

REFERENCES
Almaguer, W., Estupinan, B., Frey, J. U., & Bergado, J. A. (2002). Aging impairs amygdalahippocampus interactions involved in hippocampal LTP. Neurobiology of Aging, 23(2),
319–324. http://doi.org/10.1016/S0197-4580(01)00278-0
Bailey, D. J., Kim, J. J., Sun, W., Thompson, R. F., & Helmstetter, F. J. (1999). Acquisition of
fear conditioning in rats requires the synthesis of mRNA in the amygdala. Behavioral
Neuroscience, 113(2), 276–282.
Baraibar, M. A., & Friguet, B. (2012). Changes of the proteasomal system during the aging
process. In T. Grune (Ed.), Progress in Molecular Biology and Translational Science (Vol.
109, pp. 249–275). Progress in molecular biology and translational science.
http://doi.org/10.1016/B978-0-12-397863-9.00007-9
Barnes, C. A. (1998). Memory Changes during Normal Aging. In R. Kesner & J. J. Martinez
(Eds.), Neurobiology of Learning and Memory (pp. 247–287). Elsevier.
http://doi.org/10.1016/b978-012475655-7/50008-3
Beylin, A. V., Gandhi, C. C., Wood, G. E., Talk, A. C., Matzel, L. D., & Shors, T. J. (2001). The
role of the hippocampus in trace conditioning: temporal discontinuity or task difficulty?
Neurobiology of Learning and Memory, 76(3), 447–461.
http://doi.org/10.1006/nlme.2001.4039
Bruchey, A. K., & Gonzalez-Lima, F. (2008). Behavioral, Physiological and Biochemical
Hormetic Responses to the Autoxidizable Dye Methylene Blue. American Journal of
Pharmacology and Toxicology, 3(1), 72–79.
Burke, S. N., & Barnes, C. A. (2006). Neural plasticity in the ageing brain. Nature Reviews
Neuroscience, 7(1), 30–40. http://doi.org/10.1038/nrn1809
Cabeza, R., Grady, C. L., Nyberg, L., McIntosh, A. R., Tulving, E., Kapur, S., et al. (1997). Agerelated differences in neural activity during memory encoding and retrieval: a positron
emission tomography study. Journal of Neuroscience, 17(1), 391–400.
Callaway, N. L., Riha, P. D., Bruchey, A. K., Munshi, Z., & Gonzalez-Lima, F. (2004).
Methylene blue improves brain oxidative metabolism and memory retention in rats.
Pharmacology, Biochemistry, and Behavior, 77(1), 175–181.
http://doi.org/10.1016/j.pbb.2003.10.007
Callaway, N. L., Riha, P. D., Wrubel, K. M., McCollum, D., & Gonzalez-Lima, F. (2002).
Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome
oxidase in rats. Neuroscience Letters, 332(2), 83–86.
Chen, C., & Tonegawa, S. (1997). Molecular genetic analysis of synaptic plasticity, activitydependent neural development, learning, and memory in the mammalian brain. Annual
Review of Neuroscience, 20, 157–184. http://doi.org/10.1146/annurev.neuro.20.1.157
Chen, H.B., Wei, B., Wang, W., Zhou, P.L., Zhan, J.Q., Hu, M.R., et al. (2015). Cognitive
decline is associated with reduced surface GluR1 expression in the hippocampus of aged
rats. Neuroscience Letters, 591, 176–181. http://doi.org/10.1016/j.neulet.2015.02.030
Chondrogianni, N., Sakellari, M., Lefaki, M., Papaevgeniou, N., & Gonos, E. S. (2014).
36

Proteasome activation delays aging in vitro and in vivo. Free Radical Biology and Medicine,
71(C), 303–320. http://doi.org/10.1016/j.freeradbiomed.2014.03.031
Chondrogianni, N., Voutetakis, K., Kapetanou, M., Delitsikou, V., Papaevgeniou, N., Sakellari,
M., et al. (2015). Proteasome activation: An innovative promising approach for delaying
aging and retarding age-related diseases. Ageing Research Reviews, 23(Pt A), 37–55.
http://doi.org/10.1016/j.arr.2014.12.003
Clark, R. E., & Squire, L. R. (1998). Classical conditioning and brain systems: The role of
awareness. Science, 280(5360), 77–81.
Connor, D. A., & Gould, T. J. (2016). The role of working memory and declarative memory in
trace conditioning. Neurobiology of Learning and Memory, 134(Part B), 193–209.
http://doi.org/10.1016/j.nlm.2016.07.009
Cook, C., Gass, J., Dunmore, J., Tong, J., Taylor, J., Eriksen, J., et al. (2009). Aging is not
associated with proteasome impairment in UPS reporter mice. PLoS ONE, 4(6), e5888.
http://doi.org/10.1371/journal.pone.0005888
Cowansage, K. K., Shuman, T., Dillingham, B. C., Chang, A., Golshani, P., & Mayford, M.
(2014). Direct reactivation of a coherent neocortical memory of context. Neuron, 84(2), 432–
441. http://doi.org/10.1016/j.neuron.2014.09.022
Craik, F. I. M., & Rose, N. S. (2012). Memory encoding and aging: a neurocognitive
perspective. Neuroscience and Biobehavioral Reviews, 36(7), 1729–1739.
http://doi.org/10.1016/j.neubiorev.2011.11.007
Craik, F. I., & McDowd, J. M. (1987). Age differences in recall and recognition. Journal of
Experimental Psychology: Learning, Memory, and Cognition, 13(3), 474–479.
http://doi.org/10.1037/0278-7393.13.3.474
Daselaar, S. M., Fleck, M. S., Dobbins, I. G., Madden, D. J., & Cabeza, R. (2006). Effects of
healthy aging on hippocampal and rhinal memory functions: an event-related fMRI study.
Cerebral Cortex (New York, N.Y. : 1991), 16(12), 1771–1782.
http://doi.org/10.1093/cercor/bhj112
Daselaar, S. M., Veltman, D. J., Rombouts, S. A. R. B., Raaijmakers, J. G. W., & Jonker, C.
(2003). Neuroanatomical correlates of episodic encoding and retrieval in young and elderly
subjects. Brain : a Journal of Neurology, 126(Pt 1), 43–56.
Davis, S., Salin, H., Helme-Guizon, A., Dumas, S., Stéphan, A., Corbex, M., et al. (2000).
Dysfunctional regulation of alphaCaMKII and syntaxin 1B transcription after induction of
LTP in the aged rat. The European Journal of Neuroscience, 12(9), 3276–3282.
Ding, Q., & Zhu, H. (2015). Alteration of Proteasome System in Aging and Aging-Associated
Disorders. International Journal of Drug Development and …, 7(4), 27–30.
Drag, L. L., & Bieliauskas, L. A. (2010). Contemporary review 2009: cognitive aging. Journal of
Geriatric Psychiatry and Neurology, 23(2), 75–93.
http://doi.org/10.1177/0891988709358590
Driscoll, I., & Sutherland, R. J. (2005). The aging hippocampus: navigating between rat and
human experiments. Reviews in the Neurosciences, 16(2), 87–121.
37

Driscoll, I., Hamilton, D. A., Petropoulos, H., Yeo, R. A., Brooks, W. M., Baumgartner, R. N., &
Sutherland, R. J. (2003). The aging hippocampus: cognitive, biochemical and structural
findings. Cerebral Cortex (New York, N.Y. : 1991), 13(12), 1344–1351.
http://doi.org/10.1093/cercor/bhg081
Driscoll, I., Howard, S. R., Stone, J. C., Monfils, M. H., Tomanek, B., Brooks, W. M., &
Sutherland, R. J. (2006). The aging hippocampus: a multi-level analysis in the rat.
Neuroscience, 139(4), 1173–1185. http://doi.org/10.1016/j.neuroscience.2006.01.040
Ehlers, M. D. (2003). Activity level controls postsynaptic composition and signaling via the
ubiquitin-proteasome system. Nature Neuroscience, 6(3), 231–242.
http://doi.org/10.1038/nn1013
Einarsson, E. Ö., & Nader, K. (2012). Involvement of the anterior cingulate cortex in formation,
consolidation, and reconsolidation of recent and remote contextual fear memory. Learning &
Memory (Cold Spring Harbor, N.Y.), 19(10), 449–452.
http://doi.org/10.1101/lm.027227.112
Erickson, C. A., & Barnes, C. A. (2003). The neurobiology of memory changes in normal aging.
Experimental Gerontology, 38(1-2), 61–69.
Fanselow, M. S. (1980). Conditional and unconditional components of post-shock freezing.
Pavlovian Journal of Biological Sciences, 15, 177–182.
Foster, T. C., & Kumar, A. (2002). Calcium dysregulation in the aging brain. Neuroscientist,
8(4), 297–301.
Frick, K. M., Baxter, M. G., Markowska, A. L., Olton, D. S., & Price, D. L. (1995). Age-related
spatial reference and working memory deficits assessed in the water maze. Neurobiology of
Aging, 16(2), 149–160.
Galeffi, F., Shetty, P. K., Sadgrove, M. P., & Turner, D. A. (2015). Age-related metabolic
fatigue during low glucose conditions in rat hippocampus. Neurobiology of Aging, 36(2),
982–992. http://doi.org/10.1016/j.neurobiolaging.2014.09.016
Gallagher, M., Burwell, R., & Burchinal, M. (1993). Severity of spatial learning impairment in
aging: development of a learning index for performance in the Morris water maze.
Behavioral Neuroscience, 107(4), 618–626.
Giannini, C., Kloß, A., Gohlke, S., Mishto, M., Nicholson, T. P., Sheppard, P. W., et al. (2013).
Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat
brain. PLoS ONE, 8(5), e64042. http://doi.org/10.1371/journal.pone.0064042
Gilinsky, A. S., & Judd, B. B. (1994). Working memory and bias in reasoning across the life
span. Psychology and Aging, 9(3), 356–371.
Gilmartin, M. R., & Helmstetter, F. J. (2010). Trace and contextual fear conditioning require
neural activity and NMDA receptor-dependent transmission in the medial prefrontal cortex.
Learning & Memory (Cold Spring Harbor, N.Y.), 17(6), 289–296.
http://doi.org/10.1101/lm.1597410
Gilmartin, M. R., Miyawaki, H., Helmstetter, F. J., & Diba, K. (2013). Prefrontal activity links
nonoverlapping events in memory. Journal of Neuroscience, 33(26), 10910–10914.
http://doi.org/10.1523/JNEUROSCI.0144-13.2013
38

Golomb, J. D., Peelle, J. E., Addis, K. M., & Kahana, M. J. (2008). Effects of adult aging on
utilization of temporal and semantic associations during free and serial recall. Memory &
Cognition, 36(5), 947–956. http://doi.org/10.3758/MC.36.5.947
Gonzalez-Lima, F., & Bruchey, A. K. (2004). Extinction memory improvement by the metabolic
enhancer methylene blue. Learning & Memory (Cold Spring Harbor, N.Y.), 11(5), 633–640.
http://doi.org/10.1101/lm.82404
Han, C. J., OTuathaigh, C. M., van Trigt, L., Quinn, J. J., Fanselow, M. S., Mongeau, R., et al.
(2003). Trace but not delay fear conditioning requires attention and the anterior cingulate
cortex. Proceedings of the National Academy of Sciences of the United States of America,
100(22), 13087–13092. http://doi.org/10.1073/pnas.2132313100
Hedden, T., & Gabrieli, J. D. E. (2004). Insights into the ageing mind: a view from cognitive
neuroscience. Nature Reviews Neuroscience, 5(2), 87–96. http://doi.org/10.1038/nrn1323
Hegde, A. N. (2010). The ubiquitin-proteasome pathway and synaptic plasticity. Learning &
Memory (Cold Spring Harbor, N.Y.), 17(7), 314–327. http://doi.org/10.1101/lm.1504010
Hegde, A. N., Inokuchi, K., Pei, W., Casadio, A., Ghirardi, M., Chain, D. G., et al. (1997).
Ubiquitin C-Terminal Hydrolase Is an Immediate-Early Gene Essential for Long-Term
Facilitation in Aplysia. Cell, 89(1), 115–126. http://doi.org/10.1016/S0092-8674(00)80188-9
Helmstetter, F. J., Parsons, R. G., & Gafford, G. M. (2008). Macromolecular synthesis,
distributed synaptic plasticity, and fear conditioning. Neurobiology of Learning and
Memory, 89(3), 324–337. http://doi.org/10.1016/j.nlm.2007.09.002
Henley, J. M., & Wilkinson, K. A. (2013). AMPA receptor trafficking and the mechanisms
underlying synaptic plasticity and cognitive aging. Dialogues in Clinical Neuroscience,
15(1), 11–27.
Houston, F. P., Stevenson, G. D., McNaughton, B. L., & Barnes, C. A. (1999). Effects of age on
the generalization and incubation of memory in the F344 rat. Learning & Memory (Cold
Spring Harbor, N.Y.), 6(2), 111–119.
Howland, R. H. (2016). Methylene Blue The Long and Winding Road from Stain to Brain: Part
1. Journal of Psychosocial Nursing and Mental Health Services, 54(9), 21–24.
http://doi.org/10.3928/02793695-20160920-04
Hung, A. Y., Sung, C. C., Brito, I. L., & Sheng, M. (2010). Degradation of Postsynaptic Scaffold
GKAP and Regulation of Dendritic Spine Morphology by the TRIM3 Ubiquitin Ligase in
Rat Hippocampal Neurons. PLoS ONE, 5(3), e9842.
http://doi.org/10.1371/journal.pone.0009842
Jarome, T. J., & Helmstetter, F. J. (2013). The ubiquitin-proteasome system as a critical regulator
of synaptic plasticity and long-term memory formation. Neurobiology of Learning and
Memory, 105, 107–116. http://doi.org/10.1016/j.nlm.2013.03.009
Jarome, T. J., & Helmstetter, F. J. (2014). Protein degradation and protein synthesis in long-term
memory formation. Frontiers in Molecular Neuroscience, 7(61), 1–12.
http://doi.org/10.3389/fnmol.2014.00061
Jarome, T. J., Kwapis, J. L., Ruenzel, W. L., & Helmstetter, F. J. (2013). CaMKII, but not
protein kinase A, regulates Rpt6 phosphorylation and proteasome activity during the
39

formation of long-term memories. Frontiers in Behavioral Neuroscience, 7, 115.
http://doi.org/10.3389/fnbeh.2013.00115
Jarome, T. J., Werner, C. T., Kwapis, J. L., & Helmstetter, F. J. (2011). Activity dependent
protein degradation is critical for the formation and stability of fear memory in the
amygdala., 6(9), e24349. http://doi.org/10.1371/journal.pone.0024349
Jouvenceau, A., & Dutar, P. (2006). A role for the protein phosphatase 2B in altered
hippocampal synaptic plasticity in the aged rat. Journal of Physiology, Paris, 99(2-3), 154–
161. http://doi.org/10.1016/j.jphysparis.2005.12.009
Kandel, E. R. (2001). The molecular biology of memory storage: a dialogue between genes and
synapses. Science, 294(5544), 1030–1038. http://doi.org/10.1126/science.1067020
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000). Possible involvement of proteasome
inhibition in aging: implications for oxidative stress. Mechanisms of Ageing and
Development, 113(1), 61–70.
Knight, D. C., Cheng, D. T., Smith, C. N., Stein, E. A., & Helmstetter, F. J. (2004). Neural
substrates mediating human delay and trace fear conditioning. Journal of Neuroscience,
24(1), 218–228. http://doi.org/10.1523/JNEUROSCI.0433-03.2004
Knight, D. C., Nguyen, H. T., & Bandettini, P. A. (2006). The role of awareness in delay and
trace fear conditioning in humans. Cognitive Affective & Behavioral Neuroscience, 6(2),
157–162. http://doi.org/10.3758/CABN.6.2.157
Kochli, D. E., Thompson, E. C., Fricke, E. A., Postle, A. F., & Quinn, J. J. (2015). The amygdala
is critical for trace, delay, and contextual fear conditioning. Learning & Memory (Cold
Spring Harbor, N.Y.), 22(2), 92–100. http://doi.org/10.1101/lm.034918.114
Koen, J. D., & Yonelinas, A. P. (2014). The effects of healthy aging, amnestic mild cognitive
impairment, and Alzheimer's disease on recollection and familiarity: a meta-analytic review.
Neuropsychology Review, 24(3), 332–354. http://doi.org/10.1007/s11065-014-9266-5
Kwapis, J. L., Jarome, T. J., Lee, J. L., & Helmstetter, F. J. (2015). The retrosplenial cortex is
involved in the formation of memory for context and trace fear conditioning. Neurobiology
of Learning and Memory, 123, 110–116. http://doi.org/10.1016/j.nlm.2015.06.007
Kwapis, J. L., Jarome, T. J., Schiff, J. C., & Helmstetter, F. J. (2011). Memory consolidation in
both trace and delay fear conditioning is disrupted by intra-amygdala infusion of the protein
synthesis inhibitor anisomycin. Learning & Memory (Cold Spring Harbor, N.Y.), 18(11),
728–732. http://doi.org/10.1101/lm.023945.111
Lee, S.H., Choi, J.H., Lee, N., Lee, H.R., Kim, J.I., Yu, N.K., et al. (2008). Synaptic Protein
Degradation Underlies Destabilization of Retrieved Fear Memory. Science, 319(5867),
1253–1256. http://doi.org/10.1126/science.1150541
Lehmann, G., Udasin, R. G., & Ciechanover, A. (2016). On the linkage between the ubiquitinproteasome system and the mitochondria. Biochemical and Biophysical Research
Communications, 473(1), 80–86. http://doi.org/10.1016/j.bbrc.2016.03.055
Livnat-Levanon, N., & Glickman, M. H. (2011). Ubiquitin–Proteasome System and
mitochondria — Reciprocity. BBA - Gene Regulatory Mechanisms, 1809(2), 80–87.
http://doi.org/10.1016/j.bbagrm.2010.07.005
40

Long, L.H., Liu, R.L., Wang, F., Liu, J., Hu, Z.L., Xie, N., et al. (2009). Age-related synaptic
changes in the CA1 stratum radiatum and spatial learning impairment in rats. Clinical and
Experimental Pharmacology & Physiology, 36(7), 675–681. http://doi.org/10.1111/j.14401681.2008.05132.x
Lopez-Salon, M., Alonso, M., Vianna, M. R., Viola, H., Mello e Souza, T., Izquierdo, I., et al.
(2001). The ubiquitin-proteasome cascade is required for mammalian long-term memory
formation. The European Journal of Neuroscience, 14(11), 1820–1826.
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The Hallmarks
of Aging. Cell, 153(6), 1194–1217. http://doi.org/10.1016/j.cell.2013.05.039
Löw, P. (2011). The role of ubiquitin-proteasome system in ageing. General and Comparative
Endocrinology, 172(1), 39–43. http://doi.org/10.1016/j.ygcen.2011.02.005
Mabb, A. M., & Ehlers, M. D. (2010). Ubiquitination in postsynaptic function and plasticity.
Annual Review of Cell and Developmental Biology, 26, 179–210.
http://doi.org/10.1146/annurev-cellbio-100109-104129
Makrides, S. C. (1983). Protein synthesis and degradation during aging and senescence.
Biological Reviews of the Cambridge Philosophical Society, 58(3), 343–422.
Martinez, J. L., Jensen, R. A., & Vasquez, B. J. (1978). Methylene blue alters retention of
inhibitory avoidance responses. Physiological Psychiatry, 6(3), 387–390.
Martinez-Vicente, M., Sovak, G., & Cuervo, A. M. (2005). Protein degradation and aging.
Experimental Gerontology, 40(8-9), 622–633. http://doi.org/10.1016/j.exger.2005.07.005
McEchron, M. D., Bouwmeester, H., Tseng, W., Weiss, C., & Disterhoft, J. F. (1998).
Hippocampectomy disrupts auditory trace fear conditioning and contextual fear conditioning
in the rat. Hippocampus, 8(6), 638–646. http://doi.org/10.1002/(SICI)10981063(1998)8:6&lt;638::AID-HIPO6&gt;3.0.CO;2-Q
McEchron, M. D., Cheng, A. Y., & Gilmartin, M. R. (2004). Trace fear conditioning is reduced
in the aging rat. Neurobiology of Learning and Memory, 82(2), 71–76.
http://doi.org/10.1016/j.nlm.2004.06.002
Medina, D. X., Caccamo, A., & Oddo, S. (2011). Methylene blue reduces aβ levels and rescues
early cognitive deficit by increasing proteasome activity. Brain Pathology (Zurich,
Switzerland), 21(2), 140–149. http://doi.org/10.1111/j.1750-3639.2010.00430.x
Monti, L. A., Gabrieli, J. D. E., Reminger, S. L., Rinaldi, J. A., Wilson, R. S., & Fleischman, D.
A. (1996). Differential effects of aging and Alzheimer's disease on conceptual implicit and
explicit memory. Neuropsychology, 10(1), 101–112. http://doi.org/10.1037/08944105.10.1.101
Morris, K. A., & Gold, P. E. (2012). Age-related impairments in memory and in CREB and
pCREB expression in hippocampus and amygdala following inhibitory avoidance training.
Mechanisms of Ageing and Development, 133(5), 291–299.
http://doi.org/10.1016/j.mad.2012.03.004
Moyer, J. R., & Brown, T. H. (2006). Impaired trace and contextual fear conditioning in aged
rats. Behavioral Neuroscience, 120(3), 612–624. http://doi.org/10.1037/0735-7044.120.3.612
41

Naveh-Benjamin, M. (2000). Adult age differences in memory performance: tests of an
associative deficit hypothesis. Journal of Experimental Psychology: Learning, Memory, and
Cognition, 26(5), 1170–1187.
Naveh-Benjamin, M., Hussain, Z., Guez, J., & Bar-On, M. (2003). Adult age differences in
episodic memory: further support for an associative-deficit hypothesis. Journal of
Experimental Psychology: Learning, Memory, and Cognition, 29(5), 826–837.
http://doi.org/10.1037/0278-7393.29.5.826
Newman, M. C., & Kaszniak, A. W. (2000). Spatial Memory and Aging: Performance on a
Human Analog of the Morris Water Maze. Aging, Neuropsychology, and Cognition
(Neuropsychology, Development and Cognition: Section B), 7(2), 86–93.
http://doi.org/10.1076/1382-5585(200006)7:2;1-U;FT086
Nilsson, L., BÄCkman, L., & Erngrund, K. (1997). The Betula prospective cohort study:
Memory, health, and aging. Aging, 4(1), 1–32.
Nilsson, L.-G. (2003). Memory function in normal aging. Acta Neurologica Scandinavica,
107(s179), 7–13. http://doi.org/10.1034/j.1600-0404.107.s179.5.x
Oler, J. A., & Markus, E. J. (1998). Age‐related deficits on the radial maze and in fear
conditioning: Hippocampal processing and consolidation. Hippocampus, 8(4), 402–415.
http://doi.org/10.1002/(SICI)1098-1063(1998)8:4<402::AID-HIPO8>3.3.CO;2-U
Ortman, J. M., Velkoff, V. A., & Hogan, H. (2014). An aging nation: the older population in the
United States. 2014 (pp. 1–28). U.S. Census Bureau (Ed.).
Oz, M., Lorke, D. E., Hasan, M., & Petroianu, G. A. (2010). Cellular and molecular actions of
Methylene Blue in the nervous system. Medicinal Research Reviews, 31(1), 93–117.
http://doi.org/10.1002/med.20177
Paban, V., Fauvelle, F., & Alescio-Lautier, B. (2010). Age-related changes in metabolic profiles
of rat hippocampus and cortices. The European Journal of Neuroscience, 31(6), 1063–1073.
http://doi.org/10.1111/j.1460-9568.2010.07126.x
Park, D. C., Lautenschlager, G., Hedden, T., Davidson, N. S., Smith, A. D., & Smith, P. K.
(2002). Models of visuospatial and verbal memory across the adult life span. Psychology and
Aging, 17(2), 299–320. http://doi.org/10.1037//0882-7974.17.2.299
Pavlov, P. I. (2010). Conditioned reflexes: An investigation of the physiological activity of the
cerebral cortex. Annals of Neurosciences, 17(3), 136–141. http://doi.org/10.5214/ans.09727531.1017309
Peter, C., Hongwan, D., Kupfer, A., & Lauterburg, B. H. (2000). Pharmacokinetics and organ
distribution of intravenous and oral methylene blue. European Journal of Clinical
Pharmacology, 56(3), 247–250.
Petersen, R. C., Smith, G., Kokmen, E., Ivnik, R. J., & Tangalos, E. G. (1992). Memory
Function in Normal Aging. Neurology, 42(2), 396–401.
Provyn, J. P., Sliwinski, M. J., & Howard, M. W. (2007). Effects of age on contextually
mediated associations in paired associate learning. Psychology and Aging, 22(4), 846–857.
http://doi.org/10.1037/0882-7974.22.4.846
42

Quinn, J. J., Loya, F., Ma, Q. D., & Fanselow, M. S. (2005). Dorsal hippocampus NMDA
receptors differentially mediate trace and contextual fear conditioning. Hippocampus, 15(5),
665–674. http://doi.org/10.1002/hipo.20088
Quinn, J. J., Oommen, S. S., Morrison, G. E., & Fanselow, M. S. (2002). Post-training
excitotoxic lesions of the dorsal hippocampus attenuate forward trace, backward trace, and
delay fear conditioning in a temporally specific manner. Hippocampus, 12(4), 495–504.
http://doi.org/10.1002/hipo.10029
Reis, D. S., Jarome, T. J., & Helmstetter, F. J. (2013). Memory formation for trace fear
conditioning requires ubiquitin-proteasome mediated protein degradation in the prefrontal
cortex. Frontiers in Behavioral Neuroscience, 7. http://doi.org/10.3389/fnbeh.2013.00150
Riha, P. D., Bruchey, A. K., Echevarria, D. J., & Gonzalez-Lima, F. (2005). Memory facilitation
by methylene blue: Dose-dependent effect on behavior and brain oxygen consumption.
European Journal of Pharmacology, 511(2-3), 151–158.
http://doi.org/10.1016/j.ejphar.2005.02.001
Riha, P. D., Rojas, J. C., & Gonzalez-Lima, F. (2011). Beneficial network effects of methylene
blue in an amnestic model. NeuroImage, 54(4), 2623–2634.
http://doi.org/10.1016/j.neuroimage.2010.11.023
Roberson, E. D., Defazio, R. A., Barnes, C. A., Alexander, G. E., Bizon, J. L., Bowers, D., et al.
(2012). Challenges and opportunities for characterizing cognitive aging across species.
Frontiers in Aging Neuroscience, 4, 6. http://doi.org/10.3389/fnagi.2012.00006
Rojas, J. C., Bruchey, A. K., & Gonzalez-Lima, F. (2012). Neurometabolic mechanisms for
memory enhancement and neuroprotection of methylene blue. Progress in Neurobiology,
96(1), 32–45. http://doi.org/10.1016/j.pneurobio.2011.10.007
Ross, J., Olson, L., & Coppotelli, G. (2015). Mitochondrial and Ubiquitin Proteasome System
Dysfunction in Ageing and Disease: Two Sides of the Same Coin? International Journal of
Molecular Sciences, 16(8), 19458–19476. http://doi.org/10.3390/ijms160819458
Rowe, J. W., & Kahn, R. L. (1987). Human aging: usual and successful. Science, 237(4811),
143–149.
Rönnlund, M., Nyberg, L., Bäckman, L., & Nilsson, L.-G. (2005). Stability, growth, and decline
in adult life span development of declarative memory: cross-sectional and longitudinal data
from a population-based study. Psychology and Aging, 20(1), 3–18.
http://doi.org/10.1037/0882-7974.20.1.3
Saez, I., & Vilchez, D. (2014). The Mechanistic Links Between Proteasome Activity, Aging and
Age-related Diseases. Current Genomics, 15(1), 38–51.
http://doi.org/10.2174/138920291501140306113344
Schirmer, R. H., Adler, H., Pickhardt, M., & Mandelkow, E. (2011). "Lest we forget you-methylene blue...". Neurobiology of Aging, 32(12), 2325.e7–16.
http://doi.org/10.1016/j.neurobiolaging.2010.12.012
Singer, T., Verhaeghen, P., Ghisletta, P., Lindenberger, U., & Baltes, P. B. (2003). The fate of
cognition in very old age: six-year longitudinal findings in the Berlin Aging Study (BASE).
Psychology and Aging, 18(2), 318–331. http://doi.org/10.1037/0882-7974.18.2.318
43

Smith, C. D., Walton, A., Loveland, A. D., Umberger, G. H., Kryscio, R. J., & Gash, D. M.
(2005). Memories that last in old age: motor skill learning and memory preservation.
Neurobiology of Aging, 26(6), 883–890.
http://doi.org/10.1016/j.neurobiolaging.2004.08.014
Steenland, H. W., Li, X. Y., & Zhuo, M. (2012). Predicting Aversive Events and Terminating
Fear in the Mouse Anterior Cingulate Cortex during Trace Fear Conditioning. Journal of
Neuroscience, 32(3), 1082–1095. http://doi.org/10.1523/JNEUROSCI.5566-11.2012
Stoehr, J. D., & Wenk, G. L. (1995). Effects of age and lesions of the nucleus basalis on
contextual fear conditioning. Psychobiology, 23, 173–177.
Telch, M. J., Bruchey, A. K., Rosenfield, D., Cobb, A. R., Smits, J., Pahl, S., & Gonzalez-Lima,
F. (2014). Effects of Post-Session Administration of Methylene Blue on Fear Extinction and
Contextual Memory in Adults With Claustrophobia. American Journal of Psychiatry,
171(10), 1091–1098. http://doi.org/10.1176/appi.ajp.2014.13101407
Tomaru, U., Takahashi, S., Ishizu, A., Miyatake, Y., Gohda, A., Suzuki, S., et al. (2012).
Decreased proteasomal activity causes age-related phenotypes and promotes the
development of metabolic abnormalities. The American Journal of Pathology, 180(3), 963–
972. http://doi.org/10.1016/j.ajpath.2011.11.012
Tulving, E. (1987). Multiple memory systems and consciousness. Human Neurobiology, 6(2),
67–80.
Uttl, B., & Graf, P. (1993). Episodic spatial memory in adulthood. Psychology and Aging, 8(2),
257–273.
Vechio, F. H. D., Cerqueira, F., Augusto, O., Lopes, R., & Demasi, M. (2014). Peptides that
activate the 20S proteasome by gate opening increased oxidized protein removal and reduced
protein aggregation. Free Radical Biology and Medicine, 67(C), 304–313.
http://doi.org/10.1016/j.freeradbiomed.2013.11.017
Villarreal, J. S., Dykes, J. R., & Barea-Rodriguez, E. J. (2004). Fischer 344 rats display agerelated memory deficits in trace fear conditioning. Behavioral Neuroscience, 118(6), 1166–
1175. http://doi.org/10.1037/0735-7044.118.6.1166
Wainwright, M., & Crossley, K. B. (2002). Methylene Blue - a therapeutic dye for all seasons?
Journal of Chemotherapy, 14(5), 431–443. http://doi.org/10.1179/joc.2002.14.5.431
Ward, M. T., Oler, J. A., & Markus, E. J. (1999). Hippocampal dysfunction during aging I:
Deficits in memory consolidation. Neurobiology of Aging, 20(4), 363–372.
http://doi.org/10.1016/S0197-4580(99)00045-7
Weike, A. I., Schupp, H. T., & Hamm, A. O. (2007). Fear acquisition requires awareness in trace
but not delay conditioning. Psychophysiology, 44(1), 170–180.
http://doi.org/10.1111/j.1469-8986.2006.00469.x
Wrubel, K. M., Barrett, D., Shumake, J., Johnson, S. E., & Gonzalez-Lima, F. (2007a).
Methylene blue facilitates the extinction of fear in an animal model of susceptibility to
learned helplessness. Neurobiology of Learning and Memory, 87(2), 209–217.
http://doi.org/10.1016/j.nlm.2006.08.009
Wrubel, K. M., Riha, P. D., Maldonado, M. A., McCollum, D., & Gonzalez-Lima, F. (2007b).
44

The brain metabolic enhancer methylene blue improves discrimination learning in rats.
Pharmacology, Biochemistry, and Behavior, 86(4), 712–717.
http://doi.org/10.1016/j.pbb.2007.02.018
Zelikowsky, M., Hersman, S., Chawla, M. K., Barnes, C. A., & Fanselow, M. S. (2014).
Neuronal ensembles in amygdala, hippocampus, and prefrontal cortex track differential
components of contextual fear. Journal of Neuroscience, 34(25), 8462–8466.
http://doi.org/10.1523/JNEUROSCI.3624-13.2014

45

Shane E. Pullins
Address:

224 Garland Hall
2441 E. Hartford Ave.
Milwaukee, Wisconsin 53211

414-229-4979
spullins@uwm.edu

EDUCATION:
University of Wisconsin – Milwaukee, Milwaukee, Wisconsin
Doctoral Student in Experimental Psychology | August, 2014 – Present
Major: Neuroscience
G.P.A.: 4.0
Miami University, Oxford, Ohio
B.S. & B.A. in Zoology | May, 2014
Minor in Neuroscience
RESEARCH EXPERIENCE:
Graduate Research Assistant | August, 2016 - Present
Principal Investigator: Fred Helmstetter, Ph.D.
Undergraduate Research Assistant | October, 2011 – July, 2014
Principal Investigator: Jennifer Quinn, Ph.D.
AWARDS AND FELLOWSHIPS:
University of Wisconsin-Milwaukee – Graduate Student Excellence Fellowship | May, 2017
University of Wisconsin-Milwaukee – Department of Psychology Summer Research Fellowship |
May, 2015
Society for Neuroscience - Faculty for Undergraduate Neuroscience Travel Award | November, 2013
Miami University - Student Enrichment Funding Award | October, 2013
Miami University - Undergraduate Presentation Award | October, 2013
Miami University - Undergraduate Summer Scholarship | May, 2013
Miami University - Undergraduate Presentation Award | October, 2012
PUBLICATIONS:
Pullins, SE, Cullen PK, Ferrara NC, Helmstetter, FJ. In Preparation. Age-related deficits in trace fear
conditioning and activity-dependent protein degradation.
Pullins, SE, Cullen PK, Ferrara NC, Helmstetter, FJ. In Preparation. Contributions of the retrosplenial cortex to
event-related and contextual memory formation.
Cullen PK, Pullins SE, Ferrara NC, Hintz J, Helmstetter FJ. In Preparation. Optogenetic stimulation of central
nucleus of the amygdala-ventral periaqueductal gray results in consummatory behavior.

46

Cullen PK, Ferrara NC, Pullins SE, Helmstetter FJ. In Preparation. Expression of fear memory is maintained
across a distributed neural network.
Ferrara NC, Cullen PK, Pullins SE, Rotondo EK, Helmstetter FJ. 2017. Input from the medial geniculate
nucleus modulates amygdala encoding of fear memory discrimination. Learning and Memory. 24(9):
414-421. doi: 10.1101/lm.044131
Cullen PK, Ferrara NC, Pullins SE, Helmstetter FJ. 2017. Context memory formation requires activity
dependent protein degradation in the hippocampus. Learning and Memory. 24(11): 589-596. doi:
10.1101/lm.045443.117.
Pierson, JL, Pullins, SE, Quinn, JJ. 2015. Dorsal hippocampus infusions of CNQX into the dentate gyrus
disrupt expression of trace fear conditioning. Hippocampus. doi:10.1002/hipo.22413

POSTER PRESENTATIONS:
Pullins, S.E., Cullen, P.K., Ferrara, N.F., Cruz, W.C., Helmstetter, F.J. 2017. Contributions of the retrosplenial
cortex to event-related and contextual fear memory formation in trace fear conditioning. The Society
for Neuroscience Annual Meeting, Washington D.C.
Pullins, S.E., Cullen, P.K., Ferrara, N.F., Cruz, W.C., Helmstetter, F.J. 2017. Contributions of the retrosplenial
cortex to event-related and contextual fear memory formation in trace fear conditioning. The
Pavlovian Society Annual Meeting, Philadelphia.
Cruz, W.C., Pullins, S.E., Moyer, J.R. Jr., Helmstetter, F.J. 2017. The effects of methylene blue on trace fear
memory and brain proteolytic activity in young and aged rats. The Society for Neuroscience Annual
Meeting, Washington D.C.
Pullins, S.E., Cullen, P.K., Ferrara, N.F., Moyer, J.R. Jr., Helmstetter, F.J. 2016. Activity-dependent protein
degradation and age-related memory impairment. The Society for Neuroscience Annual Meeting, San
Diego.
Cullen, P.K., Ferrara, N.C., Pullins, S.E., Hintz, J., Helmstetter, F.J. 2016. Behavioral expression of a fear
memory is maintained by neural activity in a distributed brain network throughout CS presentation.
The Society for Neuroscience Annual Meeting, San Diego.
Ferrara, N.C., Cullen, P.K., Rotondo, E.K., Pullins, S.E., Helmstetter, F.J. Medial geniculate nucleus input
modulates amygdala encoding of fear memory discrimination. The Society for Neuroscience Annual
Meeting, San Diego.
Cullen, P.K., Ferrara, N.C., Pullins, S.E., Helmstetter, F.J. 2015. Neural activity in the lateral amygdala driven by
auditory CS onset critically determines memory retrieval and behavioral expression of fear. The
Society for Neuroscience Annual Meeting, Chicago.
Beeman C.L., Pullins, S.E., Hoogendoorn, J.J., Quinn, J.J. 2014. Complete hippocampal lesions disrupt recent
and remote trace fear memories regardless of the lesion-to-test interval. The Pavlovian Society
Annual Meeting, Seattle.
Pierson, J.L., Pullins, S.E., Quinn, J.J. 2014. Dorsal hippocampus infusions of CNQX into the dentate gyrus
disrupt expression of trace fear conditioning. The Pavlovian Society Annual Meeting, Seattle.

47

Pullins, S.E., Beeman, C.L., Hoogendoorn, J.J., Quinn, J.J. 2013. Temporally-graded retrograde amnesia
following trace fear conditioning: Focal hippocampus damage or distal disruption? The Society for
Neuroscience Annual Meeting, San Diego.
Quinn, J.J., Skipper, R.A., Pullins, S.E., Damas-Vannucchi, I., Martin, K., Powers, L., Renda, M., Reser, K.M.,
Ronau, R., Schaefer, M., Wilber, J., Wilkins, B., Winfield, M. 2013. Growing neuroscientists: Sparking an
interest in elementary students. The Society for Neuroscience Annual Meeting, San Diego.
Beeman, C.L., Hoogendoorn, J.J., Pullins, S.E., Quinn, J.J. 2013. Characterizing the effects of complete
hippocampal lesions on trace and contextual fear conditioning following a 30 day lesion-to-test
interval. The Society for Neuroscience Annual Meeting, San Diego.
Pullins, S.E., Pierson, J.L., Burton, J.M., Quinn, J.J. 2012. Immunohistochemical analysis of the dorsal
hippocampus during recent and remote fear memory retrieval. The Society for Neuroscience Annual
Meeting, New Orleans.
Pierson, J.L., Pullins, S.E., Quinn, J.J. 2012. Expression of trace fear conditioning requires the dentate gyrus,
but not CA1 or CA3, of the dorsal hippocampus. The Society for Neuroscience Annual Meeting, New
Orleans.
ORAL PRESENTATIONS AND INVITED TALKS:
Pullins, S.E., Cullen, P.K., Helmstetter, F.J. 2017. Contributions of the retrosplenial cortex to event-related and
contextual memory formation. Invited symposium speaker at the Midwestern Psychological
Association Meeting, Chicago, Illinois.
Pullins, S.E., Cullen, P.K., Helmstetter, F.J. 2017. Contributions of the retrosplenial cortex to event-related and
contextual memory formation. Oral presentation at AGSIP Symposium, University of Wisconsin –
Milwaukee.
Pullins, S.E., Cullen, P.K., Helmstetter, F.J. 2017. Contributions of the retrosplenial cortex to event-related and
contextual memory formation. Oral presentation at UWM Spring Neuroscience Symposium,
University of Wisconsin – Milwaukee.
Pullins, S.E. April 2016. Age-related deficits in trace fear conditioning and activity related protein
degradation. Oral presentation at AGSIP Symposium, University of Wisconsin – Milwaukee.

TEACHING AND OUTREACH:
Association for the Advancement of University Women, University of Wisconsin – Milwaukee,
Milwaukee, Wisconsin
Assistant Teacher | August 2016 – Present
Molecular Basis of Memory, University of Wisconsin – Milwaukee, Milwaukee, Wisconsin
President | August 2017 – Present
Guest Lecture: Psychopharmacology, Introduction to Neuropsychology - University of Wisconsin –
Milwaukee, Milwaukee, Wisconsin | February 2017
Molecular Basis of Memory, University of Wisconsin – Milwaukee, Milwaukee, Wisconsin
Vice President | August 2016 – August 2017

48

Teaching Assistant, University of Wisconsin – Milwaukee, Milwaukee, Wisconsin
Behavioral Neuroscience Laboratory | Spring, 2016
Teaching Assistant, University of Wisconsin – Milwaukee, Milwaukee, Wisconsin
Behavioral Neuroscience Laboratory | Fall, 2015
Teaching Assistant, University of Wisconsin – Milwaukee, Milwaukee, Wisconsin
Introduction to Physiological Psychology | Spring, 2015
Teaching Assistant, University of Wisconsin – Milwaukee, Milwaukee, Wisconsin
Administrative Assistant | Fall, 2014
Nu Rho Psi Gamma in Ohio, Miami University, Oxford, Ohio
President | November 2012 – May 2014
Talawanda-Miami Science Week, Miami University, Oxford, Ohio
Assistant Teacher | Spring 2013, Spring 2014
Distinguished Undergraduate Teaching Fellowship, Miami University, Oxford, Ohio
Psychopharmacology | Spring 2014
Distinguished Undergraduate Teaching Fellowship, Miami University, Oxford, Ohio
Introduction to Biopsychology | Fall 2013
Teaching in Neuroscience Capstone, Miami University, Oxford, Ohio
Assistant Teacher | Spring, 2013
SKILLS/TECHNIQUES:
Rodent Behavior: Pavlovian context fear conditioning, Pavlovian cued fear conditioning, fear extinction,
maternal separation, restraint stress, open field analysis, elevated plus maze analysis, forced swim testing,
chronic variable stress
Biological: fluorescent in situ hybridization, surgical cannulation, tissue extraction and sectioning,
fluorescent microscopy, western blotting, optogenetics, confocal microscopy, immunohistochemistry,
immunofluorescence, retrograde tract tracing
Software: SPSS, GraphPad Prism, Freescan and Freeze Frame, ImageJ, GeneSys, MedPC/MedAssociates

49

